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Microbiota 
1.1. What is it and how it is formed? 
All alive organisms in the earth, including animals and plants, have coevolved with the 
microorganisms in their environment, as microbes colonise the host greatly influencing its 
physiology and immunity1. The term “microbiota” refers to a community of living organisms 
cohabiting in a determined niche. Animal intestines represent a favorable ecologic niche, the 
human colon is one of the most densely populated 
communities, exceeding the soil or the ocean2. The 
mammalian large intestine, is colonised by a 
number of microorganisms reaching levels of 1012 -
1014, more than the number of human cells3. The 
microbial ecosystem of the intestine, called the gut 
microbiota, includes many species that 
permanently inhabit the gastrointestinal tract and 
a variable series of microorganisms that only do so 
transitorily. The microorganisms, their genes, and 
their secreted metabolites are commonly known as 
the “microbiome”. The human microbiome 
comprises the total population of microbes 
colonising the human body, including the oral 
cavity, nasopharynx, respiratory tract, 
gastrointestinal tract, genitourinary tract, and skin4 
(Figure 1). However, recently, the term 
“microbiome” has been frequently used 
interchangeably with microbiota5. 
Figure 1: Mosaic of the microbiomes of the human body (Illustration by Charis Tsevis). 
 
The axenic epithelial surfaces of all vertebrates are colonised at birth by large 
communities of microorganisms from the environment which form commensal or mutualistic 
relationship with their host6. Many microorganisms fail to colonise a host because their 
requirements are not compatible with the conditions and resources in the host.  Conversely, 
others are able to grow and elevate their population. Microbe-microbe interactions are complex 
and diverse relationships, which are able to drive shifts in microbiome composition that are 
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generally decisive. They might be competitive, parasitic or predatory, while others are 
mutualistic. Furthermore, different types of interactions can occur simultaneously7 and be 
influenced by different processes and environmental factors which strongly contribute to 
model the microbiota composition8 such as age, or diet9. However, the initial environmental 
microbial diversity exerts significant variations in the final microbial community of the host 
even more to these environmental factors, leading to interindividual variations 10. 
 
1.2. The importance for the host 
The intestinal microbiota is widely considered a real organ with well-defined functions, 
composed of different microbes that communicate with each other and with the host. This 
microbiome exerts an enormous impact on the nutritional and health status of the host, 
developing a number of immune and metabolic functions11 (Figure 2), including: 
• The maintenance of barrier homeostasis 
The intestinal epithelium constitutes a physical barrier that regulates the 
transport of substances. The intestinal microbiota contribute to the 
maintenance of the integrity of the intestinal barrier through the maintenance 
of cell junctions, and the promotion of epithelial repair after damage12.  
• Immune system development and activation 
The intestinal microbiota is essential for the development and maturation of the 
immune system, playing an important role in the prevention of pathogenic 
infection13, and contributing to the secretion of antimicrobial peptides. It 
influences the content of lamina propia T cells, immunoglobulin A-producing B 
cells, intraepithelial T cells and serum immunoglobulin levels14.  
• Structural and metabolic functions 
Microbes provide enzymes and regulate the expression of genes involved in the 
utilisation of carbohydrates and lipids, maximising the caloric availability of 
ingested nutrients15. They contribute to cholesterol reduction, the biosynthesis 
of vitamins and isoprenoids, and the metabolism of amino acids. One of the most 
important metabolic functions of the intestinal microbiota is the utilisation of 
non-digestible carbohydrates from the diet that the human intestine cannot 
digest or absorb, into short-chain fatty acids (SCFAs)16, principally acetic, 
propionic, and butyric acid. In addition, it appears that the microbiota is capable 
of modulating the genes that regulate the energy absorption of dietary 
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carbohydrates and complex lipids by the host, which increases fat storage and 
leads to body weight gain17.  
• Furthermore, the intestinal microbiota have an impact on the development and 
function of organs outside the intestinal tract18. As a result, it is associated with 
brain development and subsequent behaviour, linking microbial activity to 
neurodevelopmental diseases19. 
 
Figure 2: Molecular interactions between the host, intestinal commensal bacteria and 
pathogens inside the intestine. 
 
1.3. Eubiosis and dysbiosis status 
 The microbiome seems to be almost stable during healthy adulthood, called “eubiotic 
status”. This status is characterised by the maintenance of homeostasis where a preponderance 
of potentially beneficial species versus potentially pathogenic species is essential. In 
homeostasis, immunoglobulin A (IgA) and antimicrobial peptides (AMPs) are released into the 
mucus layer, preventing the bacteria from reaching the epithelial surface. Microbe-associated 
molecular patterns (MAMPs) are bound to the epithelial Toll-like receptors (TLRs). Thus, 
microbial signalling to epithelial cells can be relayed to the underlying immune and nervous 
systems to alter gut functions. Moreover, the lamina propia is surveyed by many lymphocytes, 
phagocytic cells and other immune effector cells which maintain inflammatory cytokines in low 
concentrations. 
The opposite state is called “dysbiosis”, where “good bacteria” take over the “bad 
bacteria” meaning that they no longer have control20. Thus, dysbiosis is defined by quantitative 
Introduction 
 
6 
and qualitative microbial alterations21. Bacterial diversity is usually considered an indicator of 
health, because a healthy microbiome composition is required for a number of physiological 
functions12. In contrast, a reduced bacterial diversity has been related to a number of diseases 
such as obesity and inflammatory diseases in humans21, 22.  
Factors that can disturb the eubiosis state include: lifestyle, antibiotic treatments and 
pathogens8. Consequently, they transform the eubiosis into dysbiosis, characterised by 
alterations of the intercellular tight junctions that are responsible for maintaining the integrity 
of the intestinal mucosa23 . This alteration leads to changes in mucosal barrier permeability, 
which is crucial to prevent the access to pathogens24. Bacteria have evolved multiple methods 
of subverting epithelial defences and translocating to the lamina propia. Disrupted tight 
junctions, inflammatory signalling and epithelial cell death create gaps in the barrier, allowing 
the entry of opportunistic bacteria, antigens and toxins from the lumen, which activate the 
mucosal associated lymphatic tissue (MALT), and consequently the inflammatory cascade 
(leukocytes and cytokines)23. High levels of inflammatory cytokines, reduced mucus production 
and impaired antimicrobial production, which allow additional bacteria to reach and traverse 
the epithelial barrier, lead to intestinal and potentially systemic infections25 (Figure 3). 
 
Figure 3: The intestinal epithelial barrier. A Eubiosis. B Dysbiosis (Obtained from Parker et 
al., 2017)25. 
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Dysbiosis is also associated with the development of a number of diseases, including type 
2 diabetes, allergies, fatty liver disease, or intestinal bowel disease (IBD)26. A number of studies 
consider diet to be the major environmental factor that strongly modulates the intestinal 
ecosystem, providing selective growth advantages to certain microbial species27. Furthermore, 
the dietary composition also regulates several physiological factors which influence the 
microbial community but are currently poorly characterised28. Thus, different diets are 
associated with different microbial compositions29 and, in some cases, with diseases30. In 
addition, the microbiome response to dietary interventions is considered rapid, as it can occur 
within 24 h 31. For that reason, gut microbiota can be modulated by dietary interventions, 
stimulating the growth of potentially beneficial bacteria to improve health status32. 
 
2. Teniques for studying the microbiome 
2.1. Culture-dependent methods 
The study of human microbiome diversity started with Antonie van Leewenhoek. He 
compared his oral and faecal microbiota in the 1680s, appreciating the differences in terms of 
microbes between these two habitats and also between healthy and ill individuals33. 
Accordingly, studies of the differences in microbes at different sites of the body, and between 
healthy and diseased individuals, are as old as microbiology itself5.  
The first gut microbiome studies involved the cultivation of individual bacteria and the 
co-culture of microbial consortia34. The gut microbiome, as mentioned before, is densely 
populated but, unfortunately, contains only a small percentage of culturable microbes. Some 
components of the microbiota require special conditions for growth in culture media; therefore, 
they went undetected. For example, the colonic microbiota have approximately 800 to 1,000 
species per individual, but 62% of them remain unknown and 80% of the bacteria identified by 
metagenomics are regarded as unculturable35. For that reason, as culture-dependent 
techniques do not detect uncultivable microbes, little information about community dynamics 
is provided. However, cultivation-based approaches are still important today, as they allow the 
investigation of basic microbial interactions. For example, they are useful to explore the 
mechanisms by which individual microorganisms modulate the microbiota and host 
physiology. For that purpose they must be first isolated, identified, and then studied in pure 
cultures and microbial consortia36.  
One of the latest techniques used to culture isolates of the gut microbiota is 
“culturomics”. This approach, developed by Lagier et al., combines culture methods with mass 
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spectrometry (MALDI-TOF), to identify microorganisms, fungi and viruses in a complex 
ecosystem37 (Figure 4). Thus, culturomics represents a powerful technique that should 
revolutionise microbial culture38. 
 
Fig. 4 Schema of the culturomics technique. 
 
2.2. Molecular techniques 
The first report on the sequencing of long DNA sequences, namely by Sanger and 
Maxam-Gilbert, was published in 197739. From that date, for the next 30 years, large-scale 
sequencing projects relied on this technology40. With the development of molecular biology, 
different genomic approaches have arisen in the last 10 years for the study of microbial 
communities. These approaches include terminal-restriction fragment length polymorphism 
(T-RFLP), denaturing gradient gel electrophoresis (DGGE), temperature gradient gel 
electrophoresis (TGGE), or the automated approach for ribosomal intergenic spacer analysis 
(ARISA). Unfortunately, these methods provide little taxonomic information36. Recent PCR-
based sequencing technologies have drastically increased the throughput of microbiome 
analyses41. PCR-based sequencing allows the identification of individuals at a very low 
concentration within a complex matrix. Consequently, this technique is widely use for the 
detection of specific bacteria, whereas it is not suitable for the study of the entire microbiome42. 
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However, this approach, together with bioinformatics advancements, has opened the door to 
modern next-generation sequencing (NGS) technology36. 
 
2.3. Next-generation sequencing 
The progress in sequence technologies has revolutionised the knowledge of 
microbiological communities, specifically of the microorganisms living inside and outside the 
human body. The majority of human microbiome-based studies mainly use one of four types of 
next-generation sequencing strategies: genome sequencing, shotgun sequencing, 
transcriptome sequencing and metabolomics (Figure 5). 
 
Figure 5: Schema of NGS techniques. 
 
• Genome sequencing 
This technique is commonly used to study complex microbial communities43. It is focused 
on universal taxonomic markers such as 16S ribosomal RNA (rRNA) for bacteria, 18S rRNA for 
microeukaryotes and unicellular eukaryotes, and internal transcribed spacers (ITS) for fungal 
communities44. The most extensively used macromolecule in bacterial phylogenetic and 
taxonomic studies is the 16S ribosomal RNA (16S sRNA)45, as it is highly conserved between 
species belonging to the bacteria kingdom and some archaea. These conserved zones are 
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alternated by hypervariable species-specific regions making bacterial identification possible46. 
Universal primers are usually chosen as complementary to the conserved regions, with the 
variable region sequence in between47. Many primers are available for the amplification of 
different 16S variable regions, which should be selected based on factors such as the class of 
bacteria under investigation and the required level of taxonomic resolution (order, family, 
genus, species, etc.)48 (Figure 6). 
 
Figure 6: Different 16S rRNA variable regions (http://lutzonilab.org/16s-ribosomal-dna/).  
 
Once the primer pairs are selected, they are used to perform PCR after the community 
DNA is extracted. This process is followed by high-throughput sequencing of PCR amplicons36. 
When the sequencing has been completed, computational methods and techniques 
complementing experimental approaches are necessary to analyse the data obtained from the 
sequencer. The most frequently utilised bioinformatic software platforms are Mothur49 and 
QIIME50, which focus on exploratory analysis and visualisation of taxonomic composition.  
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Figure 7: Illumina sequencing method and bioinformatic analysis. 
 
• Shotgun sequencing 
Whole-genome shotgun sequencing extends the 16S/18S rRNA amplicon by 
sequencing random fragments of the genome, allowing the reconstruction of the entire 
microbial genome and providing information about gene content and bacterial metabolic 
pathways51. Thus, it allows taxonomy to be accurately defined at the species level, whereas 
taxonomy increases to the family or genera level in 16S rRNA sequencing52. However, WGS 
is more expensive and requires more extensive data analysis53. In addition, the generated 
gene functional information represents only potential functions since it is impossible to 
determine whether the gene is differentially expressed under the studied conditions36. 
• Transcriptome sequencing 
Metatranscriptomics analyses the RNA transcript pool expressed by a community. 
As the mere presence of a gene in a metagenome does not guarantee its expression, 
metatranscriptome sequencing provides information concerning the microbial processes 
that are active in a community. This technique allows the regulation and changes in 
microbial gene expression profiles to be monitored, which is particularly interesting in 
studies based on changes in the microbiota in response to perturbations. To date, 
metatranscriptomics have mainly been applied in environmental studies, whereas its 
application in the human microbiota is still rather limited 54. 
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• Metabolomics 
Metabolomics is the systematic study of all small molecules within a biological 
system. This approach plays a key role in connecting host phenotype and microbiome 
function and has the advantage that metabolites and metabolic pathways are relatively 
conserved across species. Coupling metabolomics with metagenomics has great potential 
to understand host-microbial interactions and the specific functions of microbes in the 
community55. However, the expansion of metabolite databases and the development of 
advanced statistical algorithms is necessary to connect these heterogeneous data 
matrices56.  
 
2.4. Human Microbiome Project  
The Human Microbiome project, an international collaborative project, was 
launched in 2007 with the aim of collecting and integrating genomic information from 
many diverse human microbiomes57. It was focused on a better understanding of the roles 
of human microbes on human biology including their relationship with health and 
disease58. Before these projects were started, several studies reported human microbiome 
data; however, this was the first multiple scaling project involving individuals from over 
the world. The project included metagenomics and 16S analysis of the microbiota 
inhabiting various body sites at different time points , and in several hundreds of healthy 
and disease-afflicted subjects. At the end, they concluded that microbes play an important 
role in the health of the host. In addition, the diversity and abundance of each host’s 
microbes varied widely among healthy subjects, depending on the unique species of 
bacteria accumulated over a lifetime59.  
 
3. Microbiome study models 
As previously described, microbial communities are complex ecosystems. The 
establishment of interactions between microbes, with the host and other environmental 
factors, such as diet, are key steps in microbial studies. To address this aim, several 
technical innovations have been developed to allow the study of whole gut microbial 
communities under physiologically relevant conditions 60. For that reason, experimental 
model systems are necessary. In vitro models are simplified model systems that allow 
mechanistic studies to be performed from the absence of a complete physiological 
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environment, and animal models, which permit the study of the microbes in an alive 
ecosystem.  
 
3.1. In vitro 
Different in vitro models have been developed from the first one described by 
Gibson and Macfarlane in 198861. They closely mimic the microbial composition and 
activity in different regions of the human gut. As an advantage, they are easy, cheap and 
highly reproducible. Moreover, it is possible to take samples during different steps and 
there are no ethical constrains60. However, they lack the ability to factor in host-specific 
modulators of the gut microbiota36. 
In vitro models can be divided into two types: luminal models and mucosal models. 
The first type ranges from the simplest batch fermentations to complex compartmental 
continuous systems. In a small reactor vessel, the gut can be approximated with a variety 
of cultures where desired conditions can be developed. Nutrients are constantly added as 
food intake and waste products are periodically removed62. In contrast, mucosal models 
are developed to study the relationship between microbes and the mucosa layer. They are 
an alternative for human mucosal studies regarding the difficulty and invasiveness of 
sampling63. 
 
3.2. In vivo 
Preferably, human microbiome studies should be performed in human clinical 
trials. Unfortunately, important ethical and economic considerations certainly restrain 
this approach. Alternatively, model organisms provide opportunities to perturb and 
study the host–microbiome interplay with a level of experimental control that is not 
achievable in human studies64. As a result, several in vivo models are currently available 
depending on the pursuit, which range from simple multicellular organism, such as the 
cnidarian Hydra65, to non-mammalian and mammalian models (Figure 8). 
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Figure 8: The structure of the microbiota across species and a table with considerations 
when choosing a model organism for studying the microbiome (Obtained from kostic et al., 
2013) 64 . 
 
The use of animal models to study the human microbiome is possible due to 
gnotobiotic animals. This term refers to individuals who harbour a previously known 
“gnoto” microbial composition “biotic”. Gnotobiotic experiments are based on the ability 
to raise animals in the absence of any microorganisms (germ-free GF) and then colonise 
them with single specific microbial species (monoassociation) or complex consortia 66. 
The concept of gnotobiotics was developed in 1896 when the first GF animals, guinea 
pigs, were raised by aseptic caesarean section and maintained for up to 13 days 67. This 
initial report was soon followed by the successful production of GF chickens, goats, birds, 
amphibians and fish68, 69. Live gnotobiotic animals provide novel methods for the 
cultivation of difficult-to-grow microbes70, offering the possibility to study host 
responses to gut microbiota and microbial products 71, biological processes72, or host-
microbe interactions73. 
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• Mammalian models 
Mammalian models offer the advantage of the community structure being 
conserved between them, almost at the phylum level. Mammals, including humans, are 
dominated by Bacteroidetes and Firmicutes74. Indeed, 99% of mouse genes are shared with 
humans at the host genetic level. The availability of both inbred and outbred strains and 
collections of knockout, knock-in, and transgenic mutants, make the murine model useful 
to study the host genetics. These advantages make murine model s the most utilised in 
human microbiome studies64. However, within mammalian models, rats and pigs may 
provide a superior model of the human gut microbiome, as they are able to retain more of 
the original input community75. In addition, pig is considered the best non-human-primate 
model for many aspects of human gastrointestinal biology76. However, mammalian models 
are expensive to maintain in controlled environments.  
There are a number of different murine models with which to study the human 
microbiota. Gnotobiotic mice colonised with a pure bacterial culture (monoassociation) 
represent the most reductionist approach for obtaining information about host -microbe 
specificity, the ecological niche of that particular microbe, and mechanisms of 
pathogenicity without competition from other species. However, it enables the study of 
specific factors involved during bacterial colonisation77. A step up in complexity, the 
association of GF animals with few (5-15) species, provides a more complex yet simple 
enough model with which to investigate host-microbe and microbe-microbe interactions. 
One of the first defined complex bacterial communities described was the so called altered 
Schaedler flora (ASF), which was primarily developed to obtain specific pathogen -free 
mice in breeding facilities78. However, the members of the ASF did not represent dominant 
human intestinal bacteria. For that reason, several models called SIHUMI (simplified 
human microbiota) were developed first in rats79 and later in mice80, 81, which also fulfilled 
some critical metabolic features. Finally, the most complex model is the human flora -
associated (HFA) rodent model. This model is developed by colonising GF mice with faecal 
suspensions originating from human donors. Investigators had hoped that HFA rodents 
would mimic the microbiota of the human intestinal tract, therefore being more relevant 
for predicting the situation in humans. However, they encountered difficulties in achieving 
an exact match in microbial profiles between donor and recipient mice microbiota 31. 
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• Non-mammalian models   
Simple animals, such as Drosophila melanogaster, the fruit fly, have contributed 
greatly to the understanding of basic cellular and developmental biology. Drosophila are 
recognised as a powerful model to study innate immunity and microbial pathogenesis . As 
they are simple microbiota, they form a tractable system with which to explore molecular 
host-microbiome interactions that may be applicable to higher-order microorganisms82. 
Zebrafish is the simplest vertebrate model with a number of features that make it 
an attractive experimental system. Despite the simple model complexity being distant 
from mammalian physiology, they are cost-effective and ethically acceptable solutions.  
 
4. Zebrafish 
4.1. General characteristics 
The zebrafish (Danio rerio) is a small subtropical freshwater fish, belonging to the 
Cyprinidae family, originally described by Hamilton from the Kosi River, Bengal in 182283 
(Figure 9). Its distribution in the wild includes rivers, small streams, channels, water ponds and 
paddy fields from Myanmar, Pakistan, India, Bangladesh, and Nepal with slightly alkaline (pH 
8) and clear water84. Zebrafish presents a high adaptability to fluctuations in water 
physicochemical conditions, due to the climate fluctuation because of the monsoon season85. 
Zebrafish can tolerate a temperature range of 15–35°C, although the optimal temperature is 
around 28°C. Similarly, it can survive in water with pH values between 5.5 and 9 and tolerate 
salinity values between 10 to 1000 μS86. 
The lifespan of zebrafish in captivity is around two to three years, although this may be 
extended to over five years in ideal conditions. They are omnivorous, primarily eating 
zooplankton, phytoplankton, insects and insect larvae, although they can eat a variety of other 
foods, such as worms and small crustaceans. In zebrafish-husbandry facilities, current feeding 
practices involve a diet based on rotifers and dried-food pellets used for other freshwater 
aquarium species. The fulfilment of nutritional requirements is essential for the fish’s survival 
during the larval stage87. Laboratory-reared zebrafish, unlike those in natural conditions, do not 
feed on the bottom of the tanks, they seek food in the water column and on the surface. For that 
reason, excessive food accumulation at the bottom can lead to water contamination88. 
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Figure 9: Picture of the appearance of a zebrafish adult (Michigan Science Art). 
 
Zebrafish are photoperiodic in their breeding, and produce embryos every morning, 
shortly after sunrise, by external fecundation. Under favourable conditions, females are able to 
spawn every two days, although the egg number produced may be variable due to stress 
factors89. Zebrafish embryonic development is very rapid: at 120 hours post-fertilisation (hpf), 
the fish’s major organs are already functional, and hatching occurs at 2.5–3 days post-
fertilisation (dpf). The embryonic stage covers from 0 to 3 dpf. This period is characterised by 
a rapid morphological transformation, and finishes at approximately 72 h with mouth 
protrusion90. In the juvenile state, the larva triples its length and progresses through a series of 
morphological changes that transform the overall body morphology into the juvenile 
configuration91. Then, larvae grow and acquire most adult characteristics, except sexual 
maturity. Finally, when they reach sexual maturity, they are considered adults, which normally 
happens at 3 months post-fertilisation92. 
 
4.2. Gastrointestinal tract 
Numerous studies have shown that intestinal architecture and anatomy in cyprinid 
teleost fish is closely related to that in mammals93. Zebrafish gut tube morphogenesis finishes 
at 34 dpf; however, the size and appearance of the epithelial cells continue to increase until the 
onset of exogenous feeding (120 dpf). Three intestinal segments may be defined based upon the 
histological appearance of the epithelial folds and the distribution of differentiated epithelial 
cell types94. The anterior intestine, often referred as to as the intestinal bulb, has a bigger lumen 
than the posterior part and may therefore function as a reservoir comparable to the stomach. 
However, like other cyprinids, zebrafish are stomachless95 (Figure 10).  
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Figure 10: Histology of zebrafish larvae (obtained from Ng et al., 2005)96. 
 
Illumination of the intestinal wall, which is transparent, reveals the presence of large 
randomly-shaped epithelial folds, resembling the finger-like intestinal villi of mammals and 
other amniotes. Fold height is smaller in the mid than in the anterior intestine. Many folds are 
oriented circumferentially, whereas a significant percentage of them are randomly organised. 
Histological sections through the anterior, mid and posterior intestinal segments reveal, as 
shown in Figure 11, that the folds are comprised of a single layer of epithelium that rests upon 
a connective tissue core similar to the lamina propia of the mammalian small intestine97.  
Epithelial cells within the intestine are joined apically through a complex set of junctional 
complexes (tight junctions, adherent junctions and desmosomes)96. These complexes act as a 
barrier, restricting the movement of membrane components between the apical and basolateral 
cellular domains. Three of the four principal cell types within the mammalian small intestinal 
epithelium, columnar-shaped absorptive enterocytes, the most numerous, goblet cells and 
enteroendocrine cells, are present within the anterior zebrafish intestine98 (Figure 11). The 
terminal region of the mild intestine is comprised of specialised enterocytes that appear to play 
a role in mucosal immunity. This region may be analogous to the mammalian ileum, where 
antigen presenting cells (M cells) and submucosal lymphoid aggregates, known as Peyer’s 
patches, are located99, 100. The short posterior segment architecture and absence of absorptive 
enterocytes, suggest that this region may be analogous to the colon of higher vertebrates97. 
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Figure 11: Histological cross section of zebrafish mid intestine. Intestinal folds are 
represented by enterocytes (triangle) and goblet cells (arrows). (Picture from Azti, non-
published).  
 
Apart from the morphological resemblance to mammals, the zebrafish intestine seems 
to also share metabolic functions. The second part of the zebrafish intestine closely resembles 
the caecum and rectum of the human large intestine in glycolysis, oxidoreductase activity, and 
the metabolism of amino acids, amine derivatives, organic acids, carboxylic acids and alcohol, 
whereas the third part of the zebrafish intestine resembles the human rectum, where only the 
metabolism of membrane lipids is enriched. Moreover, aquaporin genes are highly expressed 
in both sections101.  
 
4.3. Immune system 
Adult zebrafish have both innate and adaptive branches of the immune system, similar 
to that seen in mammals or other jawed vertebrates. It was shown that the zebrafish thymus, as 
a primary immune organ, remains rudimentary throughout the early larval stage and only 
acquires a complex shape from 4 weeks post-fertilisation (wpf)102. Thus, zebrafish appear to be 
incapable of mounting an antibody response until early adulthood, 4 wpf, before which they 
rely exclusively on innate defence mechanisms103. The late activation of the adaptive immune 
system allows the study of the innate immune system in zebrafish embryo or larvae without 
any interference from adaptive immunity. Zebrafish haematopoiesis produces most if not all 
immune mammalian differentiated cell types, including, leucocytes, macrophages, neutrophils 
and granulocytes104. As in mammals, the development of immune cells during embryogenesis 
occurs in distinct waves of primitive and definitive haematopoiesis105. The innate immune 
functions provide a robust defence, beginning early in development. Macrophages and 
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neutrophils can be recruited to the site of infection and phagocytose invading bacteria as early 
as 30 hpf and 52 hpf, respectively106, 107.    
The first line of defence in the larval zebrafish gut is formed by the anti-microbial 
peptides (AMPs) produced by the intestinal epithelial cells. AMPs are potent, broad spectrum 
antimicrobials that can kill Gram-negative and Gram-positive bacteria, enveloped viruses, fungi 
and even transformed or cancerous cells108. Multiple defensin-like genes encoding for an 
important AMP family have been discovered in zebrafish, which resemble beta-defensin family 
members of birds and mammals109. The elevated expression of beta-like defensin is found in the 
mid-intestine. Most immune cells and vacuolated (M-like) cells reside in this region, indicating 
its role in immune function110. Additional potent mechanisms of the innate immune system in 
zebrafish are reactive oxygen species (ROS), which mediate the killing of pathogens, and 
intestinal alkaline phosphatases (IAP), enzymes which are abundant in the brush border of the 
intestinal epithelial cells which dephosphorylate and detoxify the endotoxin component of 
bacterial lipopolysaccharide (LPS)111. In addition, several homologues of pattern recognition 
receptors (PRR) have been found in zebrafish112, such as TLRs. These receptors are located on 
the cell surface, on endosomal compartments and in the cytosol, and are able to sense the 
presence of pathogens or commensal microbiota by recognising MAMP113. The triggering of the 
innate immune response in zebrafish results in the transcriptional induction of well-conserved 
transcription factors, such as members of the adaptor protein MyD88114 intracellular pattern 
recognition receptor NOD2, or several cytokines and chemokines, whose function is conserved 
between zebrafish and mammals110. Some of these cytokines are NF-κB115, TNF116 or IL-1β117 
(Figure 12). This species also has an active complement system with three activation routes: 
the classical, alternative, and lectin pathways118.  
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Figure 12: Components of the TLR pathway and genes commonly induced during the innate 
immune response of zebrafish to bacterial infection (Obtained from Meijer, 2011) 112. 
 
4.4. Microbiota development 
The epithelial surfaces of zebrafish and all other vertebrates are colonised at birth by 
large communities of microorganisms that form commensal or mutualistic relationship with 
their host6. Host responses to microbial encounters frequently involve communications 
between multiple host cell lineages and tissues. Teleost possess physiological and 
immunological features common to all vertebrates as well as a complex gut microbiota97. 
 Zebrafish larvae hatch from the axenic environment within their protective chorion 
around 3dpf, when the intestine and other surfaces are colonised by microbes within 12-24 h 
119, 120. In much the same way as mammalian newborns are first colonised by microbes at birth, 
fish initially acquire their gut microbes from the environment upon opening of their digestive 
tract, which typically occurs a couple of days after hatching. Domesticated lab-reared zebrafish 
develop a gut microbiota similar to that of zebrafish born in their natural habitat121. The 
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community composition of larval zebrafish is more similar to communities associated with the 
surrounding environment than is adult zebrafish, indicating a greater role of environmental 
exposure early in development122. This is consistent with observed correlations in humans 
between birth delivery mode and the composition of the intestinal microbiota123.  
Zebrafish gut microbiota is primarily represented by Proteobacteria, Fusobacteria and 
Bacteroidetes bacterial groups at all stages of the zebrafish life cycle, representing up to 90% of 
the zebrafish intestinal microbiota, as reported in other fish species124. This core gut microbiota 
includes the genera Aeromonas, Shewanella, Pseudomonas, Stenotrophomonas, Vibrio, 
Burkholderia, DIAPhorobacter, Cetobacterium, Streptococcus, Bacillus, Cloacibacterium and 
Propionibacterium125. Among the mentioned bacterial genera taxa, Cantas et al. isolated and 
identified 13 cultivable species from the zebrafish adult intestine, such as Aeromonas 
hydrophila, Vibrio parahaemolyticus, Photobacterium damselae or Pseudomonas fluorescens126. 
This is in marked contrast to the mammalian gut microbiota, which is dominated by members 
of the Fimicutes and Bacteroidetes phyla74. Nonetheless, the zebrafish microbiota, although 
differing from the mammalian microbiota in terms of dominant phyla, induces a very conserved 
host response during colonisation and development71, modulates host metabolism, contributes 
to the normal intestinal development and function41, 30 and is also influenced by diet127. It has 
also been shown that the composition of zebrafish microbiota, like in mice, can convey disease 
susceptibility in a model of intestinal inflammation, emphasising the usefulness of zebrafish as 
a model to study host microbe interactions in health and disease128.  
 
4.5. The use of the zebrafish as an animal model  
The establishment of zebrafish as a prominent model organism was largely driven by 
the desire of developmental biologists for a genetically tractable system for understanding early 
vertebrate embryogenesis. The pioneering studies using zebrafish embryos were largely 
focused on the genetic analyses of early development and organogenesis during the first 3 
dpf129. Now, the zebrafish species have been fully characterised morphologically and 
physiologically, and the genome is fully sequenced and available130. Zebrafish share high genetic 
homology with humans, and doffers a cost-effective and ethical solution for many biomedical 
studies. According to the EU directive 2010/63/EU, zebrafish embryos are considered to be an 
alternative animal model, so their use is not restricted by regulation for animal welfare131.  
Zebrafish has a number of features that makes it an attractive research tool. It shares a 
considerable amount of homologies with humans, at the cell, tissue, organ and system levels132. 
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A single cross produces a large number of offspring, which develop rapidly. The facilities are 
simple and highly controlled, where the environment can be easily sampled and manipulated9, 
permitting statistically robust studies133. Additionally, zebrafish is relatively inexpensive to 
maintain, reducing the time and cost of carrying out in vivo investigations132. The transparency 
of embryos and larvae allowed the first successful examination of the colonisation dynamics of 
bacteria within live, developing hosts119. The ability to genetically manipulate both host cells 
and microbes to express fluorescent proteins allows for real-time non-destructive observations 
of spatial and temporal variation in host-microbe interactions in developing zebrafish134. Its 
powerful lifespan (1-2 years) allows the evolution of the relationship between the host and its 
microbiota to be studied135. 
Gnotobiotic techniques are straightforward in fishes since they develop ex utero and eggs 
can be surface-sterilised shortly after fertilisation136. Gnotobiotic studies in teleost, as in 
mammals, allow for the documentation of a broad array of host responses to gut microbiota; 
however, zebrafish have revealed advantages over mice in identifying microbial signalling 
pathways influencing development9. Nevertheless, while multi-generational gnotobiotic lines 
are able to be maintained in mice, this is not yet possible in fishes.  
The zebrafish gnotobiotic model has been widely use in mono- or simple associations 
(2 bacteria) to study the mechanisms of pathogen infections134 or the interactions between 
pathogens and probiotics137. In contrast, even though many attempts to colonise zebrafish with 
human complex associations have been performed, no clear result has yet been reported. Rawls 
et al. tested the effect of habitat in assembling a community in 2006. They reciprocally colonised 
axenic zebrafish and mice, and reported that the zebrafish colonised with mice microbiota 
changed in the proportions of divisions from the mouse input, calling this phenomena 
‘‘teleostification’’9. It was predicted that different habitats might influence the microbial 
assembly, preventing the growth of anaerobic bacteria inside the zebrafish digestive tract. In 
another attempt, Toh et al. colonised zebrafish larvae with a defined community of human gut-
derived bacterial strains in 2013. This community was based on 5 obligate and 25 facultative 
anaerobes. At 3 different time points, they only recovered 2 strains out of 30, all of which were 
facultative anaerobes. This result might be explained by the inability for selected microbes to 
adapt to oxygen exposure and the simplicity of the introduced community.  
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4.6. Zebrafish to study the impact of dietary fat on microbiome 
Research in zebrafish as a model to study the impact of dietary nutrients has been 
widely extended. There are several studies which have investigated the effect of proteins, 
gluten, or immunostimulants138, 139, on the intestinal microbiome140, 141 and immune 
system in zebrafish.  Soybean meal-based diets have been deeply studied in aquaculture 
species and zebrafish, as it is widely use as protein source in aquaculture nutrition. Many 
studies have demonstrated that soybean meal induces intestinal inflammation in 
zebrafish144, 145 and also changes intestinal microbiota in aquaculture species 142. In 
addition, zebrafish has recently gained popularity in lipid research because its lipid 
absorption and metabolism share remarkable similarities with mammals143 and the 
microbiota is also involved in both actions144. There have been many studies focused on 
the beneficial effect of bioactive compound such as Yuzu peel or green tea on lipid 
accumulation and metabolism, as a screening for human nutrition145, 146. In contrast, few 
studies have used zebrafish to study the impact of dietary fat on the intestinal microbiome. 
As a result, it is now clear that high-fat diets (HFD) led to variations in fish environment 
and on the intestinal microbiome of zebrafish at larvae and adult states 121, 147 . In contrast, 
a high-cholesterol diet (HCD) did not changed the microbial community composition of 
zebrafish larvae despite it induced inflammation148. Though there are few studies focused 
on the study of the effect of dietary fat on the zebrafish microbiome, immunity and body 
fat accumulation the relationship is not clear yet. 
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In the last 10 years, the technological revolution and advances in sequencing techniques 
have allowed the development of new technologies for the study of complex microbial 
communities. Therefore, not only has the study of the composition of the human flora advanced, 
but many diseases have also been related to changes in the microbiota, such as Alzheimer’s 
disease or intestinal bowel disease. In addition, the characterisation of the impact of diet on the 
microbiota and host’s health has been established. 
Studies performed in humans are very expensive, ethically reprehensible and difficult to 
achieve. Thanks to humanised rodent models, many advances have been accomplished, but they 
are expensive to maintain. In this context, simple animal models such as zebrafish, where all of 
these disadvantages become advantages, are desirable. Nevertheless, to date, a humanised 
zebrafish model has not been described. 
With this concern, the hypothesis of this study is that zebrafish might be a viable model 
to study the human intestinal microbiota and its relationship with diet. 
 
To demonstrate this hypothesis, the following specific objectives are proposed: 
 
1. To establish a colonisation protocol using obligate anaerobe bacterial strains in order 
to test their ability to colonise axenic zebrafish larvae intestine tract.  
 
2. To develop a humanised zebrafish model with human-derived microbiota previously 
extracted from a healthy donor to colonise axenic larvae. 
 
3. To study the effect of a high-fat diet administration in zebrafish larvae, during the 
period of 3 to 30 dpf, on the intestinal microbiome and the immune system. 
 
4. To study the effect of a high-fat diet and a high-fat diet supplemented with a 
commercial fish oil on the zebrafish adult intestinal microbiome, the immune system, 
lipid profile and predictive metabolic functions. 
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1. Abstract 
In this chapter, germ-free (GF) zebrafish larvae intestine was colonised with five 
bacterial species, members of the human gut microbiome, including obligate and facultative 
anaerobes (Escherichia coli, Enterococcus faecalis, Bifidobacterium breve, Lactobacillus casei and 
Eubacterium limosum). Larvae were infected with each bacterium (monoassociation) and with 
all bacteria (consortia), and the colonisation was monitored by culturing on different media, by 
q-PCR analysis and metabarcoding. After the infection, all the strains remain inside the 
zebrafish gut almost during 48 hours post infection (hpi). This suggests that the developing 
zebrafish could be a suitable model for studying certain species of the human gut microbiota. 
 
2. Introduction 
The human gut houses a vast microbial community that is vital for maintaining host 
health149. Considering the human body as an environment and the human microbiota the entire 
collection of microorganisms living on the surface and inside our body42 humans are called as 
“superorganisms”30. Consequently, we have two genomes, one inherited from our parents and 
the other acquired, i.e., the microbiome.  
The intestinal microbiome thrives in a nutrient rich and thermostable environment and 
provides the host with metabolic nutrition, the facilitation of energy extraction, the competitive 
exclusion of pathogenic microorganisms and many other beneficial functions150. The gut 
resident microbes are crucial for normal immune development and homeostasis, as well as 
regulatory effects on epithelial growth, differentiation and cytoprotection, thus exemplifying a 
balanced symbiotic relationship between the host and its resident bacterial flora. 
Compositional perturbations of the microbiota (dysbiosis) have been associated with diseases, 
as described in the introduction section, and allergies. Hence, maintaining compositional and 
functional stability within the gut microbiome is essential to host health, as demonstrated by 
dysbiosis detected at the onset of nonpathogenic chronic diseases36. 
The complexity and the high inter-individual variability of the human gut microbiota are 
inherent problems in the study of host-microbe interactions. GF animals offer the opportunity 
to circumvent some problems. For that reason, it would be desirable to have a simple animal 
model to study the interactions between the gut microbiota and the host9.  
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Zebrafish has become a popular new model organism for biomedical research, due to 
their physiological and genetic homology to mammals, high sensitivity to environmental 
modifications, and ease of experimental (behavioral, genetic and pharmacological) 
manipulation. In addition, its genome is fully sequenced and available, they have quick 
reproduction, potential for high-throughput screening, low cost, and at larvae state they are 
optically transparent132, 151. 
 
3. Materials and methods 
3.1. Zebrafish husbandry 
Zebrafish embryos were obtained from wild-type adult zebrafish (D. rerio, Hamilton 
1822) bred in the AZTI Zebrafish Facility (REGA number ES489010006105; Derio, Spain) 
following standard conditions. fishes were maintained at 27°C in 60 l tanks, with aerated 
freshwater; according to standard protocols152. Fish were fed with a pellet-formulated diet 
(Gemma Micro 300; Skretting) and reared on a 12 h light/12 h dark cycle. 
Convencionalized zebrafish larvae (monoassociation and consortia) were maintained 
under gnotobiotic conditions with autoclaved diet (ZF biolabs) three times per day136 and one 
medium change, for up to 10 (dpf).  
All experimental procedures were approved by the regional animal welfare body 
(NEIKER-OEBA-2015-005). 
 
3.2. Procedure for obtaining germ-free larvae  
Zebrafish embryos were collected directly from the breeding tanks immediately after 
fertilization and germ-free larvae were obtained following a well-established protocol153. 
Briefly, embryos were washed with a sterilized embryo wash buffer (EWB) solution (embryo 
water (EW): CaCl2 294 mg/ml, MgSO4 7H2O at 123.3 mg/ml, NaHCO3 at 63 mg/ml, KCl at 5.5 
mg/ml and supplemented with methylene blue 0.01% (w/v)), antibiotic solution (AB) 
(kanamycin 15 μg/ml, ampicillin 300 μg/ml and amphotericin B 1.25 μg/ml), 0.02% (w/v) 
polyvinylpyrrolidone (PVP) solution for 2 min, 0.003% (v/v) bleach solution for 1 h and finally 
with EWB solution. Afterwards, the embryos were incubated overnight in AB solution. The 
following day 50 embryos were collected and transferred to a Petri plate (5.5 cm diameter×1.0 
cm) to be immersed in 5 ml EWB solution and treated with two UV light pulses of 1.6 kV (Pulsed 
UV System XeMatica 1:2L-SA, SteriBeam Systems, GmbH) to inactivate bacteria present in the 
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sample. The entire procedure was carried out inside a laminar flow cabinet to maintain sterile 
conditions; sterile solutions and materials were also used. 
Sterility was routinely tested after 96 hpf (hours post fertilization), by culturing on 
general aerobic and yeast and molds culture media (Petrifilm aerobic, and Petrifilm yeast and 
molds count plates, 3M) and by PCR amplification using primers targeting 16S ribosomal RNA 
gene (63f: CAGGCCTAACAGATGCAAGTC and 1387r: GGGCGGWGTGTACAAGGC)154 .  
 
3.3. Germ-free larvae colonisation 
GF zebrafish laevae were colonised at 5dpf with desired bacteria (E. coli, E. faecalis, B. 
breve, L. casei and E. limosum) separately (monoassociation) and in association (consortia), 
inoculating each pure culture into the surrounding water at a final density of 107 - 108 CFU/ml. 
 
3.4. Colonisation confirmation 
Colonisation success was tested at different time points (24, 48, 72 hpi, 5 and 7 dpi). 
Three pools of five larvae were taken at each time point, euthanized with tricaine 
methanesulfonate (MS-222, Aldrich), washed and homogenized in pre-reduced Buffered 
Peptone Water, supplemented with cysteine (0.25 g/l) and K1 vitamin (0.001‰) (Oxoid). Serial 
dilutions were spotted onto Wilkins Chalgren general media; to MacConkey, KF, MRS (Oxoid) 
and Bifidobacterium agar (BD), as specific culture media in order to count and confirm each 
colony. Media were incubated at 37°C in anaerobiosis during 48 h. All the procedures, 
manipulation and incubations carried out in this section were performed inside in vivo & 
microaerophilic workstation (Ruskinn technology) maintaining anaerobic conditions. The 
identification of each suspected E. limosum colony was performed by qPCR (LightCycler 480 
Instrument II, Roche), because there was no specific medium for it. ELIM-F (5´-
GACTTAGGCGCAGAAAAATTCC) and ELIM-R (5´-CAAACCAGCCATACGGCATT). The PCR 
conditions consisted of initial activation for 10 min at 95°C, followed by 45 cycles (15 s at 95°C 
and 30 s at 60°C) and cooling at 40°C for 30 s. 
Furthermore, total genomic DNA was extracted from 3 pools of five larvae following the 
manufacturer’s instructions (QIAamp DNA mini kit, Qiagen) at 48 hpi and the microbial 
composition was characterized by Illumina sequencing of 16S rRNA gene amplicon (Biopolis, 
Valencia, Spain). The microbial community composition was characterized by sequencing the 
V3-V4 16S rRNA region using the primers S-D-Bact-0341-b-S-17 and S-D-Bact-0785-a-A-21155 
Zebrafish gut as a house for human intestinal bacteria 
38 
in an Illumina Miseq Platform. Paired reads were merged using flash156 after removing primer 
sequences with Trimmomatic. The rest of the bioinformatic analysis was performed using the 
mothur platform49 (1.37.2). The merged reads were quality trimmed (with a minimum Phred 
average quality score of 35 over a 50 bp window) and aligned against a reference SILVA 
alignment, keeping only those positions that start and stop in the same alignment space. The 
resulting sequences (median length of 414 bp) were denoised by a pre-clustering method 
allowing 1 mismatch157 as recommended158, and chimeras were removed using Uchime. For 
operational taxonomic unit (OTU) construction, reads were clustered at the genetic distance 
cut-offs 0.01 and 0.03 substitution per nucleotide, using the average linkage method. The final 
OTU table was rarefied to a depth of 3036 sequences per sample and results are shown to 97% 
sequence similarity. Graphics were drawn in excel. 
 
4. Results and discussion 
Using this protocol, all the strains included in the study were identified inside the 
zebrafish gut for 48 hpi (Figure 13), whereas previous studies only found two species in very 
low concentrations149. 
 
 
Figure 13: E. coli, E. faecalis, L. casei, B. breve and E. limosum percentage contribution in 
consortium at 48 hpi by 16S sequencing. 
 
These strains were selected because they are commensal bacteria in the human intestine, 
belong to different taxonomic filum and classes, and they are facultative and obligate anaerobes. 
E. limosum was included because Toh et al. introduced this strain in their experiment, and was 
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the only specie they found, together with Lactobacillus paracasei, inside the zebrafish gut 72 
hpi149. 
On the one hand, facultative anaerobes are able to survive up to 10 days, but obligate 
anaerobes only survive 48 h (Figure 14). This could be due to the oxygen pressure that makes 
possible facultative anaerobes growth, limiting obligate anaerobes survival149. At the beginning, 
obligate anaerobes might be able to survive in low/restricted oxygen conditions, but when 
facultative anaerobes colonise and grow obligate anaerobes die out because of the interspecific 
competition for the niche and resources9.  
Furthermore, these kinds of bacteria are not commonly found in the zebrafish gut, so 
they could find difficulties to establish themselves and grow. 
In monoassociations, in general, higher counts for all species used were monitorized. 
This could be due to the absence of interspecific competition, as well as the metabolism derived 
from the bacterial growth. 
 
Figure 14: E. coli, E. faecalis, L. casei, B. breve and E. limosum concentration inside zebrafish 
intestine (CFU/larvae), for monoassociation experiment (green) and for consortium 
(orange). 
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Therefore, we conclude that different human microbiota derived bacteria, including 
some obligate anaerobes, are able to colonise the zebrafish gut. This data suggests that using 
this method, working in anaerobiosis, to colonise the developing zebrafish could be a suitable 
model for studying the human gut microbiota, how to model it, the interactions with the host, 
and related diseases, as a result, diabetes, obesity or intestinal bowel disease. 
In the near future, we will use this protocol to, elucidate if zebrafish could be used as a 
model to study the whole human intestinal microbiota. 
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1. Abstract 
In this chapter, we took a step further to identify for the first time the bacterial phylotypes 
from human intestinal microbiota able to colonise the zebrafish larvae digestive tract. Five days 
post-fertilisation (dpf) germ-free (GF) zebrafish larvae were colonised successfully with the 
human intestinal microbiota previously extracted from a donor. The composition of the 
transferred microbial communities was analyzed by high-throughput sequencing. As a result, 
species with relevant interest because of their linkage to dysbiosis occurred in different human 
diseases, such as, Akkermansia muciniphila, Eubacterium rectale, Faecalibacterium prausnitzii, 
Prevotella spp. or Roseburia spp. were successfully transferred inside the zebrafish gut. This 
information has a remarkable interest in order to establish a simplified-human microbiota 
(SIHUMI) model in zebrafish.  
 
2. Introduction 
The human microbiota lives in a close relationship with their host, forming a complex 
and dynamic ecosystem, which has a large impact on several aspects of our physiology, 
promoting host health and fitness. The gut microbiome encodes 10 million microbial genes, 
400-fold more than the human gene complement. For that reason, the gut microbiota is widely 
recognized as an active and integral organ of the human body, which provides necessary 
functions to our life159. Host-associated microbiota is generally very diverse and differs from 
microbial communities in the external environment, but its composition is driven by poorly 
understood processes 7. 
Some of the forces that shape the composition of the gut microbiota may include 
stochastic processes such as genetic diversification, ecological drift, or deterministic 
interactions between species, individuals, and the environment, which create defined niches. 
The host also determines in diverse ways the gut environment. For example, the immune 
system can act as an environmental filter to limit or expand the available niches.  However, the 
abundance and types of nutrients acquired from the diet, including secreted molecules into the 
gut by the host, are thought to largely determine the niche space in the gut160. Furthermore, the 
gut microbiota composition varies with developmental age within an individual, as well as 
among the individuals of the same species2. 
Currently, there is a strong interest in studying the microbiota composition in the human 
gut42,10, the interactions with the host, the dietary effects28 and the relationship between the 
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microbiota dysbiosis and diseases or well-being161,12. Moreover, over the past decade, novel 
technological advances have facilitated a better understanding of the host-microbe interactome 
pathways that affect human health, diseases, and aging. These approaches include high-
throughput DNA sequencing36 or bioinformatic tools and gnotobiotic animal models162,150.  
Among the studies using animal models, Du et al.163 used human microbiota extracted from 
patients with intestinal bowel disease to colonise germ-free mice and study the changes in 
microbial composition during the disease. Chung et al.164 also used a gnotobiotic mice model 
colonised with human gut microbiota to study the gut immune maturation. Furthermore, a few 
other studies have used SIHUMI to colonise germ-free mice165 and rats79 to study the dietary 
regulation of the microbiota 166 or the effect of pathogens80.  
To date, several models of GF zebrafish have been colonised with human pathogens167, 
probiotics, or a mixture of them168. However, as mentioned in the introduction section, there 
are no reports of any SIHUMI model using zebrafish, nor a gnotobiotic model colonised with the 
total human microbiota. Currently, there is only one study published describing the colonisation 
of GF zebrafish with human derived bacteria, where only a minor number of species where 
successfully transferred (2 out of 30 species)149.  Performing the same type of experiment, we 
succeeded in transferring five out of five bacteria species, commonly found in human gut, 
including three obligate anaerobes, being all of them maintained during 48 h inside the 
zebrafish digestive tract169. 
 
3. Materials and methods 
3.1. Zebrafish husbandry and germ-free larvae 
Zebrafish embryos were obtained from wild-type adult zebrafish bred in the AZTI 
Zebrafish Facility following the standard conditions and procedures described in the previous 
chapter. Embryos were collected directly from the breeding tanks immediately after 
fertilization and GF larvae were obtained following a well-established protocol aforementioned. 
All experimental procedures were approved by the regional animal welfare body (NEIKER-
OEBA-2015-005). 
 
3.2. Human sample collection and stock preparation  
A human stool sample was aseptically collected from a healthy donor according to a 
sampling protocol approved by the Regional Health Research Ethics Committee (NEIKER-
OEBA-2015-005), and processed in less than 1 h. Ten g of stool were weighted and 
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homogenized in 100 mL of Brain Heart Infusion (Oxoid) supplemented with 0.5% (w/v) yeast 
extract (Pronadisa) + 0.0005% (w/v)  hemin (Fluka) + 0.0001% (w/v)  K1 vitamin (Fluka) + 
0.005% (w/v)  cysteine (Sigma) 60 s in a Stomacher (Masticator IUL Instrument). The slurry 
was then passed through 300, 250 and 150 µm stainless steel laboratory sieves to remove big 
particles170, aliquoted, mixed with 20% glycerol (Sigma-Aldrich) and kept at -80◦C until use. 
All the procedure was carried out inside an anaerobic chamber (invivo & microaerophilic 
workstation, Ruskinn technology) maintaining anaerobic conditions. 
 
3.3. Germ-free larvae colonisation 
Five dpf GF larvae were colonised with the human intestinal microbiota by static 
immersion following the infection protocol previously established in the first chapter with 
some modifications169. Briefly, one aliquot of the human fecal slurry was thawed at 4ºC and 
inoculated into previously oxygen reduced PBS (1X) (Fisher) medium supplemented with 
0.01% (w/v) K1 vitamin (sigma), 0.05% cysteine (Sigma) and 0.05% (w/v) yeast extract 
(Oxoid) (rPBS+) at a final density of 105 CFU/mL, inside an anaerobic chamber. Then, outside in 
aerobic conditions, it was poured into a petri dish containing zebrafish larvae inside a laminar 
flow cabinet. 
After 24 h incubating at 27◦C shaking at 50 rpm (Heidolph unimax 1010), the whole 
medium was removed, and larvae were washed with clean rPBS+ medium twice. Finally, the 
slurry was added again at a final density of 104 CFU/ml in fresh medium. Larvae were further 
incubated for 24 h. Afterword they were washed with sterile rPBS+, passed into a new petri 
dish and maintained for 6 h in fresh rPBS+ medium. To pool all samples, larvae were washed 
twice in a Tween 20 0.1% (Merck) baths and after that twice in fresh sterile PBS (1X) to remove 
bacteria attached on the skin137. Finally, larvae were collected in 6 pools of 20 individuals 
(Figure 15). GF and media controls were not taken. 
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Figure 15. Schematic overview of colonisation procedure. 
 
The toxicity of the medium, was tested as well, comparing the larvae mortality and the 
swimming behavior in the presence of rPBS+ medium with larvae in PBS shaking at 50 rpm for 
5 days. To determine the optimal bacterial concentration of the slurry for the colonisation 4 
replicates of 30 five dpf germ-free larvae were exposed to different slurry concentration: 103, 
104, 105 and 106 CFU/ml following the protocol explained above during 72 h. The larvae were 
not fed during this experiment.  
 
3.4. Analysis of community composition of microbiomes by 
metabarcoding 
Total gDNA was extracted from 6 pools of 20 human conventionalized larvae (HCONV), 
from the human feces (HUMAN) in triplicate (QIAamp DNA mini kit, Qiagen) and quantified 
using a Nanodrop 1000 spectrophotometer (Thermo). The microbial community composition 
was characterized as in chapter 1. For OTU construction, reads were clustered at the genetic 
distance cut-offs 0.01 substitution per nucleotide, using the average linkage method. Taxonomic 
assignment of the OTUs was obtained by classification with SILVA taxonomy (version 128) 
using the Wang approach171 and in some cases by BLAST (Basic Local Alignment Tool – NCBI) 
comparing the most representative sequence from the rep. file from Mothur with the database. 
Only OTUs identify in at least half of the HCONV samples were taken into account; however, in 
HUMAN samples all OTUs were considered. 
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4. Results 
During the first 24 h at least 90% of zebrafish larvae survived up to 105 CFU/ml slurry 
concentration; however, at 106 CFU/mL, less than 50% survival was detected. The optimal 
concentration to ensure at least 90% survival rate was 104 CFU/ml if the exposure time was 
increased 24h more.  
The composition of the microbial community of six pools of 20 GF larvae colonised with 
the human gut microbiota (HCONV) and the human (HUMAN) input were compared by 16S 
rRNA sequencing using an Illumina Miseq platform. The total number of sequences per sample 
was rarefied to 20961 reads and assigned to 3538 OTUs at 0.01 distance cutoff.  Among the 
OTUs detected, bacteria represented a 98.7% and 99.9% of the HUMAN and HCONV samples, 
respectively, with only a minor contribution of Archaea. All archaeal reads were affiliated with 
Methanobacteriaceae family (Euryarchaeota phylum), and most of them with the genus 
Methanobrevibacter. 
Within Bacteria, 9 phyla were found in HUMAN samples, being Firmicutes (61,04%), 
Bacteroidetes (31,80%) and Verrucomicrobia (2,98%) the most abundant. Seven out of the 9 
phyla found in HUMAN samples were also detected in HCONVs, including the three phyla 
previously mentioned, and Actinobacteria, Proteobacteria and Cyanobacteria. Among them, 
Proteobacteria was the most abundant in HCONV samples, contributing 95% of the reads, 
despite it contributed only 1% in HUMAN. Members of Tenericutes, Lentisphaerae and other 
unclassified Bacteria presenting very low proportion in HUMAN samples were not identified in 
HCONV. Finally, in some HCONV samples Chloroflexi, Parcubacteria and Saccharibacteria phyla 
were detected, in contrast to HUMAN samples where they not were identified. (Figure 16). 
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Figure 16. Relative abundance at phylum level in Human (HUMAN) and zebrafish larvae 
colonised with human intestinal microbiota (HCONV) represented in stacked bar chart. 
 
At family level, nearly 40% of the families (20) and 30% of the genera (50) detected in 
HUMAN samples were recovered inside the HCONV. The 20 families are listed in Figure 17. In 
HUMAN samples Ruminococcaceae (Firmicutes) was the predominating family, followed by 
Lachnospiraceae (Firmicutes), Prevotellaceae (Bacteroidetes) and Bacteroidaceae 
(Bacteroidetes). While in HCONV the most abundant family was Enterobacteriaceae 
(Proteobacteria), including the genera Coprococcus, Eubacterium and Faecalibacterium. The 
majority of Firmicutes families, the most abundant phylum in HUMAN samples, were also 
detected in HCONV (Lachnospiraceae, Ruminoccocaceae, Lactobacillaceae, Christensenellaceae, 
Erysipelotrichaceae, Acidaminoccocaceae, Veillonellaceae or Streptococcaceae among others) 
(Figure 17), incuding the genera Blautia, Dorea, Coprococcus, Faecalibacterium, Eubacterium, 
etc. Peptococcaceae, Clostridiaceae, Carnobacteriaceae and Defluviitaleaceae families were not 
detected in HCONV samples.  
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Figure 17. Summary of families identified only in human samples and detected in both 
human samples and colonised zebrafish (HCONV) by 16S sequencing. 
 
 
 
Figure 18. Relative abundance of families belonging to Firmicutes phylum in Human 
(HUMAN) and zebrafish larvae colonised with human intestinal microbiota (HCONV) 
represented in stacked bar chart. 
 
Similarly, HUMAN and HCONV shared half of the families within Bacteroidetes phylum 
(Figure 18). In this case, Prevotellaceae, Bacteroidaceae and Porphyromonadacedae were the 
three most abundant in both, including genera such as Prevotella, Bacteroides and 
Parabacteroides (Figure 19).  
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Figure 19. Relative abundance of different families of Bacteroidetes phylum in Human 
(HUMAN) and zebrafish larvae colonised with human intestinal microbiota (HCONV) 
represented in stacked bar chart. 
 
Verrucomicrobia was the third most abundant phylum in HUMAN samples. It was 
represented by three families, but only one (Verrucomicrobiaceae, and particularly the genus 
Akkermansia) appeared in 2 out of the 6 HCONV pools. Graphs from Verrucomicrobia and other 
phyla not detailed here are in supplementary material Figure 1. 
When samples were compared at the OTU level (0.01 distance cutoff), large quantitative 
differences were found between HUMAN and HCONV samples. Considering only OTUs 
appearing in at least one of the three HUMAN samples and half (3/6) of the HCONV samples, 
only 2.5% of total HUMAN OTUs were found in HCONV; being the HCONV community less rich 
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and less diverse. Escherichia affiliated OTU was the most abundant one inside the HCONV 
community, colonizing the 95% of the larvae.  
Of 3538 OTUs, 3270 are present in HUMAN samples, whereas 410 (12%) are recovered 
in HCONV. In HUMAN OTUs are distributed in Bacteroidetes (596), Firmicutes (2366), 
Verrucomicrobia (36), Actinobacteria (72), Proteobacteria (30), Cyanobacteria (23), 
Methanobacteria (12) and Others (146). Around 2.5% of them (85) are present in at least half 
of HCONV samples (Bacteroidetes (11), Firmicutes (49), Verrucomicrobia (1), Actinobacteria 
(5), Proteobacteria (17), Cyanobacteria (1) and Methanobacteria (1) (Figure 20). Furthermore, 
23 OTUs were detected in at least half of HCONV samples that were not recovered in in HUMAN, 
where 11 of them were human related taxons. In order to identify the most representative 
species of each OTU, we also analyzed the most representative sequence corresponding to each 
OTU in BLAST (Basic Local Alignment Search Tool- NCBI). The results showed that OTUs closely 
related to human species with scientific and medical interest, were identified (Faecalibacterium 
prausnitzii, Akkermansia municiphila, or Eubacterium rectale). These results are shown in 
Figure 21. 
 
Figure 20. Taxonomic composition of sequences retrieved from both human (HUMAN) and 
zebrafish conventionalized with human intestinal microbiota (HCONV) represented in a pie 
chart graph. Number of OTUs at 0.01 distance cutoff from each phylum are indicated in numbers. 
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Figure 21. Species that appeared in both human (HUMAN) and conventionalized zebrafish 
(HCONV). The distance cutoff was 0.01 with the corresponding taxonomic information provided by 
Mothur related to Silva database (v128, Phylum and Family). Species underlined are obligate 
anaerobes (Bergey’s manual of systematic bacteriology), species with * no information was found. 
 
5. Discussion 
In this study, we demonstrated that up to 60 human intestinal bacterial phylotypes are 
able to colonise the digestive tract of germ-free zebrafish larvae. In earlier works, mice 
intestinal microbiota was transplanted into germ-free zebrafish larvae and vice versa9; and two 
human gut-derived bacteria (E. limosum and L. paracasei) were detected as able to successfully 
colonise the developing gastrointestinal tract of germ-free larval zebrafish149. More recently, we 
were able to colonise axenic zebrafish larvae with five bacteria commonly found in human 
intestine (E. coli, E. faecalis, E. limosum, B. breve and L. casei) recovering all of them, including 
obligate anaerobes, during the first 48 h169. However, these reports did not clarify which human 
phylotypes in a complex microbiota sample were able to establish inside the zebrafish digestive 
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tract.  In this work, we have successfully colonised the digestive tract of GF zebrafish larvae with 
the whole human intestinal microbiota, adjusting the appropiate inoculum concentration to 
ensure larvae survival, and describing for the first time which human bacteria phylotypes are 
able to establish inside the zebrafish digestive tract.  Even though zebrafish larvae were able to 
survive at least 72 h in the presence of the human microbiota, we decided to perform this 
experiment during 48 h because to date obligate anaerobes are known to be able to survive 
during 48 h inside the zebrafish digestive tract169. Furthermore, maintaining the larvae 6 h in 
fresh sterile media ensured that the bacteria identified with the metabarcoding analysis were 
those that colonised the digestive tract. In fact, it is well established that food digestion lasts at 
least 6 h172. In addition, in other experiments performed in our laboratory we found that 
bacteria that do not colonise the digestive tract leave the intestine before 6 h173. In this 
experiment, we did not feed the larvae to avoid adding another variable.  
Only 2% of the OTUs present in HUMAN samples were found in HCONV, supporting the 
view that only a small subset of the human intestinal microbiota is able to colonise the zebrafish 
digestive tract149. This proportion is low in comparison with experiments performed in mice164, 
possibly because mice gut conditions are more similar to the human niche. Despite zebrafish 
lives in an aquatic habitat, the oxygen concentration in the gut might be higher than estimated. 
Another remarkable difference between zebrafish and mammals is the habitat temperature; 
human body is maintained at 35-37ºC (Celsius degree) while zebrafish are incubated at 27-
28ºC. Thus, the temperature might be one of the most limiting conditions for the human 
intestinal bacteria to colonise and grow inside the zebrafish gut, since in our experiment certain 
obligate anaerobes were able to colonise. In addition, in previous studies, using 5-7 dpf axenic 
zebrafish colonised with one 153 or several microorganisms169, 9, 149  a CFU of 104 - 105 
(CFU/larvae) was achieved inside the zebrafish. Furthermore, the slurry analyzed in human 
samples is diluted several times to prepare the colonisation inoculum. Therefore, if we compare 
the high microbial load present in the human feces with the small number of bacteria found in 
the larvae, it should be noted that it is not uncommon for only a few species of microorganisms 
to colonise the fish. Nevertheless, to resolve this premise more studies are necessary.  
The largest difference in terms of composition was the relative abundance of 
Proteobacteria in HCONV as compared to HUMAN, in particular Escherichia contributed up to 
95% in HCONV. Rawls et al.9 described that environmental factors could operate to select a 
subset of the input community prior to entry in the recipient fish digestive tract. Similarly to 
our results, the group of microorganims that increased in their experiments were gamma 
proteobacteria, particularly the Escherichia-Shigella group. Additionally, these authors did not 
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found Bacteroidetes, or obligate anaerobes in the output community presumably due to their 
restricted oxygen tolerance, since the larval and adult zebrafish gut have higher levels of oxygen 
that might exclude strictly anaerobes9 .  
In our experiment, we tried to maintain anaerobic conditions as strictly as possible and 
favored the stability of the obligate anaerobes and other fastidious microorganisms for example 
by supplementing the larvae medium with vitamins and other ingredients. This procedure 
could be key to manage human or mammals microbiota since it is mostly composed of obligate 
fastidious anaerobes. By handling fecal samples under anaerobic conditions and using oxygen 
reduced and supplemented media, we have successfully recovered several OTUs related to 
obligate anaerobes inside zebrafish (A. muciniphila, F. prausnitzii, Eubacterium spp., Roseburia 
spp., Bifidobacterium spp., Dorea longicatena).   
Despite the large differences in the composition found between HUMAN and HCONV, a 
remarkable result of our experiment is the large diversity of representative bacterial families 
from the human gut that were able to colonise the zebrafish larvae. Similarly to previous 
studies, both microbial communities were more similar at a higher taxonomic level9.  
Archaea had a very low contribution in all samples, because the primers only amplify a 
small amount of archaea sequences. In both HUMAN and HCONV this domain was represented 
by the Methanobrevibacter genus, belonging to Methanobacteriaceae family. The most 
representative OTU was affiliated with M. smithii, a methanogenic Archaea which have been 
specifically linked to altered metabolism and weight gain in the host174.  
From bacteria domain, 6 out of 9 phyla were found in HCONV samples; Firmicutes, 
Bacteroidetes, Verrucomicrobia, Proteobacteria, Actinobacteria and Cyanobacteria. Among the 
phyla detected, Firmicutes was the most abundant in HUMAN samples, which gathers 19 
families, 12 of them also recovered in HCONV (e.g. Ruminococcaceae, Lachnospiraceae, 
Veillonellaceae, Acidaminococcaceae). Those families include Faecalibacterium prausnitzii, 
Eubacterium spp. or Roseburia spp., butyrate producing bacteria that colonise the mucus layer, 
and consequently increase the butyrate bioavailability for colon epithelial cells162,175 . These 
bacteria have gained attention during the last years because of their contribution to gut 
homeostasis by preserving gut barrier functions and exerting immunomodulatory and anti-
inflammatory properties. Eubacterium rectale, F. prausnitzii, and/or R. intestinalis 
concentration markedly decreased in intestinal bowel disease176,177,178 and colorectal cancer 
patients179,180. Another relevant genus from Firmicutes phylum in HUMAN samples is Blautia 
spp., which was also recovered in HCONV, According to Xu et al., Blautia spp. may be involved in 
relieving inflammation, insulin resistance and obesity in high fat diet rats 181. Finally, the genus 
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Oscillibacter was also present in both samples, this genus has been associated with high fat diet 
obesity and diabetes182,183.  
The second most abundant phylum in Human was Bacteroidetes. In this group, four 
families from the 6 present in HUMAN samples were recovered inside the HCONV digestive 
tract, including Prevotellaceae, Porphyromonadaceae, Staphylococcaceae and Bacteroidacea. 
Prevotella members have been positively associated with high intake of carbohydrates and 
simple sugars and negatively with high intake of protein and fat of animal origin in 
humans184,28,185. The genus Bacteroides, which have significant effects on human health, has 
been most notably related to carbohydrate fermentation and catabolism of polysaccharides186. 
Differerent families of Actinobacteria phylum were also detected in HCONV samples. B. breve, 
B. longum and B. thermophilum, members of Bifidobacteriaceae, are the most valuable species 
belonging to this phylum, whose population inside the human digestive tract is suggested to 
have anti-obesogenic and anti-diabetic potential and its balance is correlated with a healthy 
status27. Moreover, the most appreciate member of the Verrucomicrobia phylum Akkermansia 
muciniphila, was found in 2 out of 6 samples in HCONV. It is the only cultivable member of 
Verrucomicrobia phylum and supposed to potentially have anti-inflammatory properties187. 
This means that A. muciniphila could be a target of study using zebrafish as animal model.  
In a previous study, Roeselers et al., studied the microbiota of different animals, including 
zebrafish from different laboratories, as well as environmental and human samples125. 
Analyzing the microbiota by tRFLP and 16S sequencing, the five most abundant families found 
in zebrafish (Aeromonadaceae, Fusobacteriaceae, Enterobacteriaceae, Vibrionaceae and 
Shewanellaceae) were not present in HUMAN samples (only Enterobacteriaceae). So, we can 
conclude that HUMAN related families that colonised the zebrafish larvae in our experiment 
were not members of the zebrafish natural microbiota. The host provides a basic niche that the 
microbial community expands and changes by its physical presence and metabolic activities. In 
addition to host habitat factors, dynamics within microbial communities interact with the host 
habitat to shape the final community9. However, an environmental and negative control might 
be necessary. 
To finish, we should note that 23 OTUs appeared only in at least half of HCONV samples; 
10 of them related to human intestinal microbiota that were not detected in HUMAN samples. 
At phyla level idem occurred; Chloroflexi, Parcubacteria, and Saccharibacteria phyla were not 
detected in HUMAN samples. This might be due to the sequencing method that is limited to a 
few thousand reads per sample, so members in low proportion in the HUMAN microbial 
community may not be detected even if they are present. Moreover, in this experiment OTUs 
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appearing in at least the half of the HCONV samples have been took into account to avoid 
random results. This threshold might be high and for that reason some taxons that might be 
able to colonise are not considered in the results. However, it may improve the intraspecific 
variation among HCONV samples, being a refinement because conventionally raised zebrafish 
larvae colonisation is not homogeneous122. 
Nevertheless, in HUMAN samples all OTUs have been considered in order to not misplace 
any taxon, even appearing in only one sample. Other 13 detected OTUs in HCONV samples were 
correlated to different environments. This might be attributable to the sterilization method that 
kill the bacteria but the DNA is still maintained in the medium. The addition of an environmental 
control and a mock community should circumvent this problem. However, this opens a field to 
the use of germ-free animals, because the axenity tests in general are done by culturing in 
general media (classical methods) or by 16S qPCR136. There is a great controversy about these 
techniques since some of them do not consider the non-cultivable viable microorganisms, and 
others do not take into account the DNA of dead bacterial. Some techniques might combine 
different methods to not detect dead bacteria, but they are expensive and time consuming188. 
To overcome this constraint, filtering the media and/or sterilizing with ultraviolet light to break 
the DNA should be taken into account for further studies.  
In conclusion, in this research we have identified a large variety of human bacterial 
phylotypes that have the ability to successfully colonise zebrafish larvae. In addition, we have 
confirmed that zebrafish might be a good candidate as a model to study different human 
intestinal microbiota members in monoassociation or even in consortia. In this experiment, we 
tested the microbiota of only one donor; however, in the future it would be desirable to analyze 
samples for other humans because there is a huge interindividual variation that could help to 
identify additional human bacteria with the ability of colonise zebrafish. Our findings open the 
door to the study of diseases related to microbes such as obesity, Crohn’s disease, colorectal 
cancer, or Alzheimer among others, using zebrafish as an animal model. Additionally, host-
microbe interactions, microbe-microbe interactions, new therapies, compound toxicity, or 
other basic and complex functions may also be studied in this model. This study opens a wide 
field in which more research is needed. Many improvements might be added in the future to 
this research. The absence of food in the present experiment can be expected to make it harder 
for some microbes to colonise. Therefore, it could be hypothesized that a greater number of 
human OTUs would have appeared in the zebrafish gut if the fish had been fed a diet. Moreover, 
Increasing the experimental time may provide information of bacterial colonisation, adaptation 
and metabolic behavior to the new environment.  
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1. Abstract 
In this chapter, the effects of a high-fat diet (HFD) after 25 days on the intestinal 
microbiota and inflammation in zebrafish was tested. Microbial composition of HFD fed animals 
was compared to controls by 16S rRNA sequencing and qPCR. The expression level of several 
genes related to inflammation was tested. Furthermore, microscopic assessment of the 
intestine was performed in both conditions.  The consumption of the HFD resulted in microbial 
dysbiosis, characterised by an increase in the relative abundance of the phylum Bacteroidetes. 
Moreover, an emerging intestinal inflammation via NF-κB factor activation was confirmed by 
the overexpression of several genes related to signalling receptors, antimicrobial metabolism 
and the inflammatory cascade. The intestinal barrier was also damaged, with an increase of 
goblet cell mucin production. This is the first study performed in zebrafish suggesting that the 
consumption of a diet enriched with 10% fat changes the intestinal microbial community 
composition, which was correlated with low-grade inflammation. 
 
2. Introduction 
The Overweight and obesity are defined as abnormal or excessive fat accumulation and 
a low-grade systemic inflammatory tone in the presence of a positive energy balance, 
representing a major risk factor for a number of chronic diseases including cancer, 
cardiovascular diseases, diabetes and premature mortality189. The consumption of a HFD is one 
of the main factors contributing to the development of obesity190. Human and animal studies 
have shown that both HFD and obesity are associated with changes in the gut microbiota, 
reducing the abundance and diversity of microorganisms42, 191 and impacting both 
immunological and metabolic functions of the host 192, 193. To date, studies performed in 
zebrafish describe microbial community changes or inflammation developed by the 
consumption of a high-fat, high-protein diet121, 141, 194 or a high-cholesterol diet (HCD)148. To our 
knowledge, this is the first study relating HFD consumption to microbial changes and 
inflammation in zebrafish. 
Studies performed in rodents have shown that the prolonged exposure to a HFD can alter 
the intestinal microbiota and perturb immune homeostasis, inducing intestinal 
inflammation195. These alterations lead to the activation of an innate immunity-mediated 
chronic low-grade inflammation known as meta-inflammation (metabolically triggered 
inflammation)196, suspected to be chronically activated and modulated by pro-inflammatory 
cytokines. These molecules are likely to play a key role in metabolic disease pathogenesis which 
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develops locally, but becomes systemic through the release of numerous pro-inflammatory 
mediators into the blood stream197.  
Diet is an important modulator of the intestinal microbiota in humans and other 
animals190, 198 142 and associated with impairments in epithelial integrity and barrier function 
199. The intestinal mucosa is the first barrier where fat is absorbed and metabolised and might 
therefore be involved in responses triggered by dietary lipids148. Both resident antigen-
presenting cells and intestinal mucosal epithelial cells are equipped with PRR, such as TLR and 
NOD-like receptors (NLR). They detect PAMPs, for instance lipopolysaccharides (LPS), flagellin 
or peptidoglycans200, and protect the organism from harmful pathogens, thereby promoting 
repair, regeneration and immune homeostasis of the intestine201. Recent findings have 
demonstrated that fatty acids and cholesterol are able to attach to those receptors, leading to 
inflammation202 via stimulating inflammatory-signalling cascades, such as the IκBα 
kinase/nuclear factor-KB (IKK/ NF-κB), the endoplasmic reticulum (ER), the stress-induced 
unfolded protein response (UPR) and the NOD-like receptor P3 (NLRP3) inflammasome 
pathway203. 
The zebrafish has an increasing recognition as an excellent animal model for studying 
human metabolic or inflammatory diseases due to its similarity to humans in terms of organs 
and genomic content, its highly conserved biochemical and physiological pathways and the 
availability of a complete genome sequence. Despite the differences between the zebrafish and 
mammal microbiota composition, dominated by Proteobacteria in zebrafish and by Firmicutes 
and Bacteroidetes in mice and humans, the responses to microbial colonisation are similar71. 
The microbiota also plays a crucial role in immunity and host response to pathogens in 
zebrafish111, 204, 205. 
Moreover, pathways regulating microbial recognition and activation of the innate 
immune response are also greatly conserved206. In addition, zebrafish maintenance and 
manipulation are cheaper than in rodent models132, 207, 208. In the present work, we described 
for the first time the correlation between intestinal microbiota dysbiosis and inflammation in 
zebrafish, induced by the consumption of a high-fat diet over the period of 25 days. 
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3. Materials and methods 
3.1. Zebrafish husbandry and experimental diets 
Zebrafish embryos were obtained as described in chapter 1. Embryos were collected 
directly from the breeding tanks immediately after fertilisation and transferred to 2-L fish 
tanks. At five days dpf, 200 larvae were equally separated into two tanks and subjected to the 
control and the HFD. Both were maintained in 500 mL of isowater (CaCl2 294 mg.L-1, MgSO4 123 
mg.L-1, NaHCO3 64.7 mg.L-1, LCl 5.7 mg.L-1) at 27°C for one month (30 dpf). Concentrations of 
nitrate, nitrite and ammonium were tested weekly (data not shown). All experimental 
procedures were approved by the regional animal welfare body (NEIKER-OEBA-AZTI14-005). 
The control diet consisted of a commercial diet for zebrafish larvae (ZF Biolabs), prepared 
in Milli-Q water (1g in 100 ml water)136 and autoclaved (Supplementary material, Table 1). The 
HFD consisted of the autoclaved control diet supplemented with cocoa butter to reach a fat 
content of 10% (w/w)146. Zebrafish larvae were fed three times per day during the experimental 
period, increasing the amount of food over time to facilitate normal zebrafish development209. 
At 30 mins after feeding, the remaining food was removed. Additionally, at the end of the day, 
half of the medium was replaced by fresh isowater. 
 
3.2. Bacterial DNA extraction and quantification   
After 30 dpf, five control larvae and five HFD larvae were immersed in a bath of sterile 
0.01% Tween20 (Merck) and subsequently in two consecutive baths of sterile isowater in order 
to remove any bacteria from the skin137. Then, each larva was placed in a sterile Eppendorff vial 
and immediately frozen in liquid nitrogen. Samples were stored at −80°C until further use. 
Genomic DNA was extracted from frozen samples using a QIAamp DNA Mini Kit (Qiagen LTD, 
West Sussex, UK), following the manufacturer’s instructions. The DNA concentration and purity 
were analysed using a Nanodrop (Thermo), measuring the absorbance at 260 nm and the 
A260/A280 ratio, respectively.  
 
3.3. Analysis of the microbial community composition 
Characterisation of the microbial community composition was performed on an Illumina 
Miseq Platform by sequencing the V3-V4 16S rRNA region, as described in chapter 1. 
Furthermore, the total number of bacteria per sample was quantified by qPCR, as previously 
described210. Alpha diversity measures were calculated in Mothur and R (3.4.0): number of 
observed species (SOBS), species richness (Chao1), community evenness (Simpson´s evenness) 
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and diversity (Shannon). Beta diversity was analysed from a Bray Curtis distance matrix in a 3-
dimensional non-multimetric scaling plot (NMDS). Differences between treatments were 
determined with AMOVA (Mothur). Comparisons at different taxonomical levels were 
compared using the Kolmogorov-Smirnov test. Discriminatory analysis between treatments at 
the OTU level was performed with the LEfSe command implemented in Mothur. Pearson 
correlation among genes, phylotypes and goblet cell counts was accomplished using the 
Corrplot and Hmisc R packages. 
All sequences from this study are available from the European Nucleotide Archive 
(ENA) (PRJEB23882). 
 
3.4. Gene expression analysis by real-time PCR (qPCR) 
To study gene expression levels, groups of 20 larvae were sampled at 30 dpf. Three 
replicates per diet were analysed in two independent experiments. At the end of the 
experimental period, zebrafish larvae were immediately frozen in liquid nitrogen and stored at 
-80C until being processed. Total RNA was extracted using TRIzol Reagent (Invitrogen) 
according to the manufacturer’s instructions. The quantity and quality of RNA samples were 
determined by capillary electrophoresis, using an Agilent 2100 Bioanalyzer (Agilent 
Technologies); only RNA samples with an RNA integrity number (RIN) of at least 8.5 were used 
211. 
A reverse transcription reaction was performed with the Taqman Reverse Transcription 
Kit (Applied Biosystems), using synthesised cDNAs from the RNA samples containing 20 ng of 
RNA per assay. The mixture was incubated at 25°C for 10 min and at 48°C for 30 min, and the 
enzyme was inactivated at 95°C for 10 min. Changes in mRNA expression of the genes related 
to the innate immune system (ASC, CASPA, IL10, IL1B, IL22 TNFA, NFKB and MYD88), host-
microbe interactions (TLR4, TLR5, TLR2, MMP9, MPO, NOD1 and DEF1) and metabolic activity 
(IAP) were monitored by qPCR, using β-actin (ACT) and elongation factor 1 (EF1) as reference 
genes to normalise the results. The primer sequences are listed in table 1. Quantitative PCR was 
carried out with a Light Cycler 480 sequence detection system (Roche Diagnostics). Each 
reaction was performed in a 10 µL solution containing 300 nM primers, 5 µL 2x Brilliant III 
SYBR Green qPCR Master Mix (Agilent) and 10 ng of cDNA template, as previously described134. 
The qPCR efficiency was maintained between 90 and 110%. 
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Table 1. Gene expression primer list. (* refers to this work) 
Gene Short Forward primer Reverse primer Ref 
Caspase recruitment 
domain 
ASC GCTTCCTCTAAGGCTGTAAGCAA GATGAAGTTTACCTTACCTTGGAGAAAGCA 148 
Caspase 1a CASPA ACTTCATTTCTCTGATGTCGTGCA CATGCCGGTAAGATTTGGTGT * 
Interleukin-1 β IL1B CATTTGCAGGCCGTCACA GGACATGCTGAAGCGCACTT 212 
Interleukin 10 IL10 ATATTTCAGGAACTCAAGCGGG ACTTCAAAGGGATTTTGGCAAG * 
Interleukin 22 IL22 TGAGGGAGGGTCTGCACAG GCATGGCTCATAAGCACTTGTT * 
Tumor necrosis factor  TNFA ACCAGGCCTTTTCTTCAGGT GCATGGCTCAAAGCACTTGTT * 
Nuclear factor-kB NFKB AGAGAGCGCTTGCGTCCTT TTGCCTTTGGTTTTTCGGTAA 134 
Myeloid differentiation 
primary response 88 
MYD88 CACAGGAGAGAGAAGAGTCACAG ACTCTGACAGTAGCAGATGAAAGCAT * 
Matrix metallopeptidase 
9 
MMP9 TTGGCTTCTGTCCCAGTGAG TTAGGGCAGAATCCATACTT 213 
Myeloid-specific 
Peroxidase 
MPO CAATGGCCCGCATAATCTG GCGAAAAGGATCTCTGGGAACT 212 
Nucleotide-binding 
oligomerization domain 
1  
NOD1 TGAGACAAACAGCGAGGACG GCAGATATGCCGTTAGCCGT * 
Toll like receptor 4 TLR4 GGGAAGTCAATCGCCTCCA ACGGCTGCCCATTATTCCT 134 
Toll like receptor 5 TLR5 CGAATCTCTTCAGCACCCTC CTGGCACACGTCACATCCTC * 
Toll like receptor 2 TLR2 GGAAGGTGGCACTAAGAGCCT TGATCGGTCGTGGAGGAGTT 212 
Defensin 1 DEF1 CTTTACTTGGGACCATTAGGCTG TTCAGTTCTCAAAGAAAATGTGATACAC * 
Intestinal alkaline 
phosphatase 
IAP ATGGGAGTGTCCACGGTTTCAG CGATGCCAACAGACTTTCCTTG 
111, 
214 
Β-actin ACT TGCTGTTTTCCCCTCCATTG TTCTGTCCCATGCCAACCA 212 
Elongation factor 1 EF1 GCCAACTTCAACGCTCAGG AGAGATCTGACCAGGGTGGTTC 215 
 
To study gene expression levels, groups of 20 larvae were sampled at 30 dpf. Three 
replicates per diet were analysed in two independent experiments. At the end of the 
experimental period, zebrafish larvae were immediately frozen in liquid nitrogen and stored at 
-80C until being processed. Total RNA was extracted using TRIzol Reagent (Invitrogen) 
according to the manufacturer’s instructions. The quantity and quality of RNA samples were 
determined by capillary electrophoresis, using an Agilent 2100 Bioanalyzer (Agilent 
Technologies); only RNA samples with an RNA integrity number (RIN) of at least 8.5 were 
used211. 
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3.5. Evaluation of intestinal mucus secretion and intestinal tract 
histology 
The intestinal mucus secretion was visualised with a Nikon SMZ1000 stereomicroscope, 
staining whole larvae with alcian blue as previously described215. Briefly, at 30 dpf, five larvae 
per treatment were analysed and processed with ‘‘Color Deconvolution’’ plug of the imageJ 
software v1.47 (National Institutes of Health, NIH) to obtain the staining area (mm2)216.  
In addition, five larvae of each treatment were fixed in 10% (v/v) neutral buffered 
formalin, dehydrated and paraffin-embedded. Subsequently, 4-µm sections were stained with 
hematoxylin and eosin as well as with alcian blue. Slides were analysed under a microscope by 
a blind pathologist. Histological damage was calculated using the following criteria: For 
mucopolysaccharide secretion, every goblet cell per intestinal crest was counted. Mucosal 
architecture and cellular infiltration were scored as follows: normal, moderate or extensive 
damage, respectively 0, 1 or 2; and normal, moderate and transmural infiltration, respectively 
0, 1 or 2. The scores for the last two criteria were then summed with a maximum possible score 
of 4, as previously described217, 218.  
 
3.6. Statistics 
The p-values were calculated with a T-test and a non-parametric Kolmogorov-Smirnov 
test, using the software package Statgraphics v16.1.17 (StatPoint Technologies, Inc.). All p-
values were adjusted via Bejamini Hochberg correction219. A p value < 0.05 was considered 
statistically significant.  
 
4. Results 
4.1. The effect of the high-fat diet consumption on intestinal microbiota 
To evaluate the effect of the diet on zebrafish microbiota, the microbial community 
composition of five larvae fed each experimental diet was analysed and described by 
metabarcoding at 30 days post-fertilisation (dpf). Compared to the control samples, HFD did 
not affect the microbial community alpha-diversity, calculated by different diversity indices 
such as community richness (measured by observed OTUs (SOBS) and Chao1 (Chao)) (Figure 
22 a). Community evenness and diversity, tested by Simpson´s evenness and Shannon indices, 
were not affected by the HFD, although they tended to decrease. Beta diversity analysis revealed 
that the overall composition of the microbial community did not show significant differences 
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due to the HFD, as control and HFD samples were clustered together in the NMDS (AMOVA test, 
P = 0.31; Figure 22 b).  
However, there were significant changes in community phylotypes. Overall, 31 phyla 
were characterised in both diet conditions, of which Proteobacteria was the most abundant one 
(59 and 66% of the sequences in control and HFD groups, respectively). However, Bacteroidetes 
were significantly increased (p < 0.01) in HFD samples (from 2 to 16% of the total sequences; 
Figure 23 a and b). The increase of Bacteroidetes due to the HFD was reflected at the family 
level in the enrichment of the Cytophagaceae family (p < 0.01), Flectobacillus, the NS11-12 
Marine Group (p < 0.01) and the genus Runella (p < 0.05; Figure 23 c). Furthermore, a tendency 
to increase in the Proteobacteria phylum was observed. In contrast, Firmicutes and 
Actinobacteria tended to decrease. Moreover, the number of total bacteria from the same larvae 
extracted DNA was quantified by qPCR, showing that the consumption of a HFD over the period 
of 25 days did not significantly modify the number of total bacteria (p = 0.60; Figure 22 c). 
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Figure 22. Alpha and beta diversity in control and HFD samples. A: Estimates of alpha-
diversity represented in boxplots. B: Non-metric multidimensional scaling plot (using Bray Curtis 
dissimilarity) of Control and HFD samples. Lower stress = 0.115; R2 = 0.894; p = 0.317, calculated 
via the AMOVA test. C: Total number of bacteria (log 16S rRNA gene copies/larva) in control and 
HFD zebrafish larvae (n = 5). Results represent the mean values of each condition in the vertical 
bars. The error bars indicate the standard error of the mean. 
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Figure 23. Relative abundance of phylum, families and genus in control and HFD. A: relative 
abundance at phylum level in larvae fed a control diet and the HFD, represented in Pie chart, and 
in a stacked bar chart (B). C: Relative abundance of Bacteroidetes at family and genus level.  
 
In addition, Linear discriminant analysis (LDA) effect size (LEfSe) was used to identify 
microbial OTUs that differed significantly between control and HFD groups. Twenty-one OTUs 
were significantly enriched or decreased in HFD samples. The OTUs affiliated to Flectobacillus, 
Runella, Flavobacterium and the NS11-12 Marine Group, Bacteroidetes phylotypes and to 
Acidovorax, Rhizobiales and Acinetobacter, Proteobacteria phylotypes, increased in HFD 
samples. In turn, OTUs affiliated to Proteobacteria, Rhodobacteraceae, Meganema and 
Rhizobiales phylotypes, Actinobacteria, Mycobacterium phylotype, and to Firmicutes, Finegoldia 
phylotype, were depleted (Figure 24). The OTU 16, related to the genus Flectobacillus, a member 
of the phylum Bacteroidetes, was the most enriched OTU in HFD samples. 
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Figure 24. Linear discriminant analysis (LDA) effect size (LEfSe). OTUs and associated OTU 
taxonomy significantly enriched in HFD and in control samples. Differences were considered 
statistically significant at p < 0.05. 
 
4.2. The effect of the high-fat diet consumption on immune system 
We assessed the expression of 16 genes related to the zebrafish immune system by qPCR 
at 30 dpf (n = 6) to test the effect of the HFD on the immune system. Specifically, NOD1, TLR2, 4 
and 5 are host receptors involved in the first contact and interaction with microbiota; ASC and 
CASPA are essential parts of the NPLR3 inflammasome; NFKB, IL10, IL22 and MYD88 take part 
in cellular signalling and the triggering of inflammation; IL1B and TNFA are cytokines 
associated to the inflammatory cascade; and finally, IAP, Defensin 1, MMP9 and MPO are 
antimicrobial peptides secreted by the host in response to microbial attacks.  
Compared with the control, the expression levels of 12 of the genes studied were 
markedly upregulated in HFD samples. The HFD consumption induced an immune response 
mediated by IL1B activation by the canonical NF-κB pathway, as MYD88, NFKB and finally IL1B 
were significantly up-regulated in HFD samples. Conversely, the NLRP3 inflammasome was not 
affected in HFD-fed animals, as CASPA and ASC gene expressions did not change. Moreover, 
TNFA and IL22, proinflammatory cytokines, were also enhanced in HFD samples. Changes in the 
microbial composition, induced by HFD consumption, also increased the expression of TRL2, 
TLR5 and NOD1 genes, receptors implicated in host-microbe interactions, and IAP, MPO, MMP9 
and Defensin 1, genes related to the secretion of antimicrobial peptides as a defence strategy 
(Figure 25). 
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Figure 25. Gene expression fold change analysis after 25 days of diet exposure (30 dpf) in 
control and HFD larvae. Error bars indicate the standard error of the mean. Differences were 
considered statistically significant at p < 0.05 (*). 
 
4.3. The effect of the high-fat diet consumption on intestinal barrier 
Alcian blue staining of five whole-mount larvae at 30 dpf revealed a statistically 
significant increase in mucus production due to HFD consumption (p < 0.05; Figure 26, A and 
B). Furthermore, to reinforce these observations, alcian blue was also used to stain histological 
preparations of larvae intestines in order to observe mucus-producing goblet cells. A 
statistically significant increase in goblet cells was observed in HFD-fed animals at 50 µm, based 
on histological preparations (p < 0.01; Figure 26, C), counting an average of 8.6 compared to 1.8 
goblet cells per crest in HFD and control animals, respectively (Figure 36, E and F). Moreover, a 
moderate loss of mucosal architecture was found in the intestinal epithelium of two out of five 
HFD-fed larvae (n = 5) with a score of 1, observing apical brush border cell fusion (Figure 26 D 
and G). We observed no infiltration of inflammatory cells, irrespective of the diet. 
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Figure 26. Histology of Control and HFD larvae. A: and B: Alcian blue-stained control larva and 
HFD larva. Arrows indicate goblet cells stained blue. C: Percentage of alcian blue-stained area in 
control and HFD larvae, represented as the mean of three replicates; error bars indicate the 
standard error of the mean. Differences were considered statistically significant at p < 0.05 (*). D 
and E: Goblet cells stained with alcian blue in control and HFD intestine histological preparations 
at 50 µm. Arrows show goblet cells. F: Histological damage in the HFD zebrafish intestine, 
hematoxylin- and eosin-stained at 50 µm. Arrows show enterocyte degeneration points. G: 
Histological assessment of intestinal damage. Values represent means ± standard error of the mean 
(SEM), with n being the number of larvae. Differences were considered statistically significant at p 
< 0.01 (**). 
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4.4. Correlation between microbial changes and inflammation 
induced by the high-fat diet consumption 
We found a positive correlation among microbial groups, which shifted between diets, 
gene expression and goblet cell count (Figure 27). The major correlations were identified 
among TNFA, MYD88, IL1B genes and goblet cell count with Bacteroidetes. The increase in TNFA 
and MYD88 gene expression levels was positively correlated to the enrichment of Bacteroidetes 
(genus Cytophaga and OTUs affiliated to Flectobacillus and Flavobacterium (16, 20, 408, 247 and 
449); R = .66-0.79; p < 0.05) and Proteobacteria (OTUs 40, 46 and 64 affiliated to Acinetobacter, 
Rhodobacter and Rhizobiales; R = 0.65-0.88; p < 0.05). The up-regulation of the NFKB gene was 
correlated to the increase of Bacteroidetes-affiliated taxa, the genus Cytophaga, Flectobacillus 
OTU 247 and Bacteroidetes unclassified OTU 147. The most correlated gene, IL1B, was strongly 
associated to the Bacteroidetes genera Flectobacillus, Emitricia, Runella, Cytophagaceae 
unclassified, UKL 13.3, the NS11-12 Marine Group and the associated OTUs 16, 449, 114, 164, 
480 and 147 (R = 0.70-0.93; p < 0.05). In addition, the overexpression of IL1B was also 
correlated to the Proteobacteria-affiliated OTUs 40 and 46 (R = 0.40-0.66; p < 0.05). The OTU 
24, related to Acinetobacter, was the most correlated OTU in the experiment, with the major 
correlation coefficients being related to the genes IL22, CASPA, IL10 and ASC (R = 0.90-0.96; p < 
0.05). 
Furthermore, the increase in goblet cells in HFD samples was significantly positively 
related with the enrichment of Bacteroidetes (Runella, Pseudarcicella and the NS11-12 Marine 
group, OTUs 20, 114 and 164; R = 0.65-0.93; p < 0.05) and to Proteobacteria (OTUs 40, 46, 64 
and 56; R = 0.65-0.81; p < 0.05). Cellular receptors TLR 2, 5 and NOD1 were positively correlated 
to Cytophagaceae unclassified, Flectobacillus and OTUs 24 and 247, related to Acinetobacter and 
Flectobacillus (R = 0.58-0.93; p < 0.05). No significant negative correlations were found. 
Significant correlations are represented in Figure 27. 
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Figure 27. Correlation plot. Pearson correlations between gene expressed, goblet cell count and 
significantly different genera within Bacteroidetes and LEfSe OTUs are represented by coloured 
dots. Positive correlations are in blue. Only significant correlations are represented (p < 0.05). 
 
5. Discussion 
 
In the present study, we report that the consumption of a 10%-fat diet, enriched with 
cocoa butter (HFD), induces intestinal microbiota dysbiosis and inflammation in zebrafish 
larvae. This reformulated “cafeteria diet” has been described to induce obesity in rats220 and 
body fat accumulation in zebrafish146. In addition, there is a strong evidence supporting that an 
overconsumption of nutrients initiates and triggers meta-inflammation, altering metabolic 
homeostasis221. Our results are in accordance with studies carried out in rodent models which 
showed that HFD consumption leads to intestinal inflammation, related to microbial 
dysbiosis191. Up to date, diet studies performed in zebrafish have focused on the effect of diets 
on other physiological aspects121, 222. Furthermore, most of these experiments were performed 
in adults146.  
In this work, we used zebrafish larvae to study the effects of a HFD on the intestinal 
microbiota and inflammation, taking into consideration that the larval adaptive immune system 
is not fully mature until 4-6 wpf and therefore does not interfere with the innate223; in addition, 
the transparency of the larvae allows whole-mount microscopy. The zebrafish anterior-mid and 
posterior gut segments are functional analogues of the mammalian small and large intestines. 
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In addition, most of the differentiated epithelial cell types found in mammals and the 
architectural organisation of the intestines are also conserved97. 
As previously shown, the gut microbiota can be directly or indirectly affected through 
diet in humans32, mice224 and zebrafish121, which can in turn influence host physiology225. In this 
report, the consumption of a high-fat diet did not affect the total number of bacterial copies and 
the alpha and beta community diversity of 30 dpf zebrafish larvae, as previously described in 
reports studying the relationship between the intestinal microbiota and a high-fat diet or 
chemically-induced inflammation121, 148, 226. Although Wong et al.121 did not reported alpha 
diversity changes with diets, they detected a significant dietary fat effect on the beta diversity 
at 35 and 75 dpf when HFD-fed larvae (28% fat) were compared to larvae fed a low-fat diet 
(10% fat). In this work, we enriched the control diet with cocoa butter for a final fat content of 
10% to study the first changes in the microbiota, which did not yet affect the community 
diversity, but induced inflammation. For that reason, this point might be critical to revert 
dysbiosis and, consequently, inflammation. Thus, nutritional intervention from an early stage 
could lead to a difference in the gut microbiota assembly, with potential consequences on host 
physiology in the adult stage121. 
Although the HFD consumption likely did not alter alpha and beta diversity, it induced 
microbial changes at different taxonomic levels. The phylum Bacteroidetes was increased via 
the HFD. At the OTU level, the majority of the OTUs significantly enriched in HFD samples were 
affiliated to Bacteroidetes of the genera Flectobacillus, Flavobacterium and Runella. Some other 
increased OTUs were members of Proteobacteria, namely of the genera Acinetobacter, 
Rhizobiales, Acidovorax and Rhodobacter, the most abundant phyla in all zebrafish 
developmental stages122. Proteobacteria and Firmicutes tended to increase and reduce, 
respectively, as described by Qi He et al.226. They also related the overrepresentation of 
Proteobacteria and the lack of Firmicutes to the up-regulation of TNFA and, finally, to intestinal 
inflammation induced by chemicals. As expected, the diet-induced inflammation only slightly 
affected the microbiota and the immune system compared to chemicals. In contrast to our 
results, Wong et al. found that Pseudomonas and Janthinobacterium were indicative of HFD gut 
microbiota at 35 dpf121. The differences to our study in terms of larvae collection time point, the 
percentage of fat content and the fatty acids present in the diet might have led to a difference in 
developmental and physiological changes. These changes influence how different dietary fat 
levels impact the assembly of gut microbiota. Moreover, dietary fatty acids may directly affect 
the microbial selection through differential microbial capabilities for lipid metabolism and 
indirectly modulate host immunity and physiology121.  
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Obesity-induced inflammatory mechanisms involve the activation of genes encoding for 
cytokines, chemokines and other immune inflammatory mediators through the activated 
transcription factors NF-κB and inflammasome, resulting in the proteolytic conversion of pro 
IL-1β to activated IL-1β227. Zebrafish possess both innate and adaptive immunity. In addition, 
key mediator-signalling proteins and cytokine112 as well as the major mammalian blood cell 
lineages206 have been identified in the zebrafish. The canonical NF-κB pathway and NLRP3 
inflammasome are also conserved between zebrafish and mammals115, 148. 
In the present study, we observed the activation of the IL1B gene by the canonical NF-κB 
pathway, suggesting that in zebrafish larvae, IL-1β might be activated by the consumption of 
HFD. In our study, IL1B was activated via the canonical NF-κB pathway. This is in agreement 
with Landgraft et al., who observed HFD-induced metabolic alterations in adult zebrafish (e.g. 
hyperglycemia and ectopic lipid accumulation in the liver and a metabolically unhealthy 
adipose tissue phenotype with adipocyte hypertrophy), accompanied by changes in the 
expression of marker genes such as IL1B 193. Our results suggest that HFD consumption induced 
changes in the relative abundance of Bacteroidetes. Specifically, these changes enriched the 
genera Flectobacillus, Cytophaga and Runella, which may activate an inflammatory response 
mediated by IL-1β via the NF-κB pathway. Furthermore, shifts in Proteobacteria in HFD 
samples were correlated to the overexpression of the TNFA gene, as previously described in a 
chemically-induced inflammation226. The activation of IL1B via the NPLR3 inflammasome was 
not up-regulated. However, there was a strong correlation between Proteobacteria OTU 24, 
affiliated with Acinetobacter, ASC and CASP1a; NPLR3 components needed to activate this 
pathway. The increase of some Proteobacteria might be correlated with the activation of the 
inflammasome. Contrary to our research, in HCD-fed larvae, IL-1β activation involved the up-
regulation of NPLR3 inflammasome components CASP1a and ASC115, which suggests that a 
high-fat non-cholesterol diet, based on cocoa butter, may specifically induce the overexpression 
of IL-1β via NF-κB. However, more research is needed to elucidate this question. 
In addition, to initiate the inflammation, the binding to cellular receptors of endogenous 
danger-associated molecular patterns (DAMPs) is required228. Orthologs of mammalian TLR 
and NLR have been identified in zebrafish112. Microbial signals such as LPS and lipid compounds 
are able to bind to these receptors, inducing expression229, 230. Dietary fatty acids affect the 
development of many human chronic diseases, in part mediated through the modulation of 
TLR231. Saturated fatty acids such as palmitate, stearate and oleate, the main components of 
cocoa butter, used to enriched the diet in the current study (HFD), can activate TLR2 and 4, 
stimulating the expression of IL1B via NF-κB232. As a result, other molecules involved in the 
inflammatory process, such as MYD88 or MMP9233, are also activated, as observed in our 
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experiment. These interactions are well described in diabetes234 or obesity232. In the present 
study, the genes TLR5, TLR2 and NOD1 were overexpressed, correlating to the increase of 
Bacteroidetes and Acinetobacter. Altogether, these results suggest that the consumption of a 
high-fat diet activates the host immune response via the NF-κB pathway, initiated by cellular 
receptor stimulation through changes in the microbial community.  
The inflammation process also triggers the secretion of a vast number of molecules by 
the host, which are required for the maintenance of the intestinal barrier function, a viscoelastic 
protective layer composed of mucins secreted by goblet cells235, defensins (including Defensin 
1)139, 236, matrix metalloproteinases (MMPs)213 and enzymes such as IAP237. As exposed earlier, 
TLR2 activation by dietary fatty acids not only induced the activation of cytokines, but also 
MMP9 secretion232. The increase in AMP (MMP9, MPO, IAP and Defensin 1) gene expression 
levels, as occurred in chemically and microbiologically induced intestinal inflammation111, 139, 
238, together with the increase in mucus production by goblet cells, correlated with the increase 
in Bacteroidetes and Proteobacteria. These results suggest that the host defence mechanisms 
are active and regulate the extracellular matrix, protecting inflammation induced by HFD 
consumption.  
In contrast, cellular infiltration was not observed in histological preparations, although 
few cellular unions were destroyed. However, the MPO gene, a factor needed for neutrophil 
migration239, was up-regulated, supporting the developing response to the barrier disruption 
by neutrophil expression. In agreement with our results, Progatzky et al.148 described that the 
accumulation of neutrophils and macrophages around the intestine, together with 
inflammasome activation, resulted from HCD consumption, leading to intestinal inflammation. 
Host physiological and morphological changes during development have significant 
effects on microbiota69. We suggest that the maturation of the innate immune system at 4-5 
weeks post fertilisation, together with the microbial colonisation and evolution in zebrafish, 
might be related to some of these changes and powerfully affected by the diet. Therefore, the 
use of this diet-induced inflammation larvae model might be highly recommended to 
understand how dietary compounds interact with the microbiota and the host innate immune 
system, with the aim to mitigate the inflammation process. In the present work, we have 
achieved a dietary-induced inflammatory state, correlated to microbial changes, in 30 days, 
whereas dietary experiments in adults generally last 6-8 weeks138, 146. The easy and cheap 
maintenance, the reproducibility and the high number of individuals achieved per spawning 
confer the high potential of this model. 
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In conclusion, the present study supports the assumption that in zebrafish, the 
consumption of a HFD over the period of one month leads to microbiota dysbiosis and intestinal 
inflammation. We suggest that the fatty acids present in a 10% fat diet, enriched with cocoa 
butter, could modify the intestinal ecosystem, changing the microbial composition and 
favouring the increase of Bacteroidetes and Proteobacteria. These bacterial changes activated 
the innate immune system, inducing an inflammation via NF-κB activation and the secretion of 
protective molecules by the host. Furthermore, the fatty acids present in the diet directly 
interacted with receptors present in the enterocytes. These interactions might damage the host 
intestinal mucosa, provoking shifts in the host immune system and physiology, thereby 
perpetuating and exacerbating the inflammation and driving and triggering an inflammatory 
response. This inflammatory state is a pivotal point to study the changes in the microbial 
composition that might lead to the development of a meta-inflammation in diet-induced obesity 
and metabolic diseases. We therefore demonstrated that zebrafish larvae are a reproducible 
and adequate model to test nutritional interventions in early stages; this model allows us to 
study the effects of a particular diet on microbiota composition and the innate immune system.  
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1. Abstract 
In this chapter the impact of a high-fat diet (HFD) and the possible beneficial effect of a 
commercial fish oil rich in docosahexaenoic acid (DHA), on the intestinal microbiome, immune 
system and lipid metabolism of zebrafish adults was analysed. First, the effect of both 
experimental diets on the lipid profile of whole fish and liver was analyzed by gas 
chromatography. Then, the modulatory effect of diets on intestinal microbiota, its metabolic 
profile and inflammatory stimulation were determined by 16S rRNA Miseq illumina sequencing 
and RNA expression level analysis. The dietary fat changed not only microbial community 
composition and metabolism, but also fish lipid profile, whereas commercial fish oil intake 
ameliorated the effect of the HFD. These results suggested that the HFD exerted changes on the 
intestinal microbial environment altering microbial composition and its metabolisms. Opposite, 
HFD supplementation with fish oil benefited the host reducing the changes provoked by the 
HFD. 
 
2. Introduction 
Obesity is a complex, multifactorial and chronic condition arising as a consequence of an 
abnormal accumulation of body fat, with a major negative impact on human health. Genetic, 
metabolic, environmental and behavioural factors are widely accepted as causal 
contributors240. Epidemiological studies have shown a positive relationship between dietary fat 
intake and obesity241. Diet may play an important role in inducing or preventing obesity by 
changing the structure and metabolism of the intestinal microbial community242. Diet-induced 
obesity is associated with a less abundant and less diverse gut microbiome31, and with an 
impact on host immunological and metabolic functions192. Thus, any factor that alters the 
microbiota could play a pivotal role in regulating this inflammation. For that reason, dietary 
components that can exert beneficial effects on the gut microbiota will be crucial for the 
prevention and treatment of chronic disease243. 
Diets rich in polyunsaturated fatty acids (PUFAs) have been shown to positively influence 
immune function, blood pressure and cholesterol and triglycerides levels in animals and 
humans244. However, western diet is rich in n-6 PUFA and deficient in n-3 PUFA245. It is well 
recognised that long-chain omega-6 PUFA (n-6 PUFA) (linoleic and arachidonic acids) and 
omega-3 PUFA (n-3 PUFA) (linolenic, eicosapentaenoic and docosahexaenoic acids) play 
important and opposing roles in the modulation of inflammation246. Generally, n-6 PUFAs 
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promote inflammation, whereas n-3 PUFAs have anti-inflammatory properties247. Since n-6 and 
n-3 long-chain PUFAs compete for the same enzymes for their synthesis and metabolism, their 
ratio in body tissues determines the profile of lipid mediators involved in the inflammatory 
response243. N-3 PUFA compete with n-6 PUFA reducing the production of n-6 PUFA-derived 
inflammatory eicosanoids, down-regulate key enzymes that synthesize lipid mediators, and 
inhibits the expression of inflammatory cytokines such as NF-κB248. Although the consumption 
of an omega-3 rich diet has beneficial effects on host health, the gut microbial changes 
associated with omega-3 fatty acids are poorly understood249, 250. Kaliannan et al. in their study 
conclude that n-3 PUFA supplementation reverts the gut dysbiosis and metabolic endotoxemia 
linked to western diet consumption243. 
In recent years the interaction between the intestinal microbiota and host metabolism has 
inspired broad interest243. Although rodent models have greatly contributed to our 
understanding251 experiments using zebrafish have increased in number. As previously 
mentioned, zebrafish digestive organs and metabolic pathways are highly conserved, and 
zebrafish microbiota also plays a crucial role in immunity and host response to pathogens205. 
Pathways regulating microbial recognition and activation of the innate immune response are 
also highly conserved252. Moreover, zebrafish lipid metabolism is very similar to that in humans 
in terms of intestinal fat absorption, transport, and storage143. Diet-induced obesity in zebrafish 
shares common pathophysiology pathways with mammalian obesity253. Due to these 
similarities, the ease of their genetic manipulation and their economic potential, zebrafish are 
increasingly being used as models of human diseases254.   
 
3. Materials and methods 
3.1. Zebrafish husbandry  
Wild-type adult zebrafish were bred and maintained in the AZTI Zebrafish Facility following 
standard conditions described in chapter 1.  All experimental procedures were approved by the 
regional animal welfare body (NEIKER OEBA-2017-002). 
 
3.2. Experimental diets 
The control diet consisted of a commercial diet for zebrafish adults (Gemma Micro 300; 
Skretting). The HFD was prepared by enriching the control diet with 20% (w/w) cocoa butter 
146. To prepare the high-fat DHA-enriched diet (HFO) the same HFD was prepared and enriched 
to a final concentration of 3% (v/w) with a commercial fish oil (85% DHA) (v/w), provided by 
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Sendabio. Briefly, to prepare the experimental diets, cocoa butter was melted and mixed with 
the commercial diet. Then the mixture was frozen for 5 minutes to allow it to solidify. It was 
then cold ground to reduce the particle diameter to appear the same as the normal diet. The 
HFO diet was prepared following the same procedure, adding the commercial fish oil rich in 
DHA after melting the cocoa butter (Supplementary Material Figure 2). 
The experimental diets were prepared weekly, dispensed in monodosis and stored at 4°C. 
The nutritional composition of all experimental diets and the stability of the DHA in HFO during 
storage were also analysed (Supplementary Material Table 2). 
 
3.3. Experimental design 
Seventy-five adult zebrafish were allocated to 3 tanks (Figure 28). Each tank was fed with 
approximately 20 mg of one of the experimental diets 3 times per day255 for 6 weeks (Control, 
HFD, HFO). Water inflow to the tanks was paused for 1 h during feeding, and fish were allowed 
to consume the diet for 45 min. After that, the surplus was removed. Twice a week the tanks 
were cleaned, and half of the medium was removed. In addition, the nitrate, nitrite and 
ammonium parameters of the water were tested to ensure the medium quality (data not 
shown). 
After 6 weeks 54 fish were anesthetised in ice and weighed. Each individual was weighed 
and blood glucose was measured with a glucometer (Contour plus, Bayer) as previously 
described256. After that they were euthanised in an ice bath257. The intestines and livers of 39 
fish were surgically removed under a stereo microscope. Extracted organs were collected in 
Eppendorf tubes for DNA and RNA extraction and for lipid profile analysis by fatty acid methyl 
esters (FAMEs). Remaining fish (n=15) were directly collected for lipid profile analysis after 
euthanasia (Figure 28). All samples were frozen directly in liquid nitrogen. Samples for lipid 
profile analysis were collected in 1 mL of ice-cold water and 10 μL of 100 mM 
ethylenediaminetetraacetic acid (EDTA) in order to stop enzymatic reactions. All samples were 
stored at -80°C until they were analysed. 
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Figure 28. Workflow of the sample collection and analysis. 
 
3.4. Lipid profile analysis 
The lipid profile of whole zebrafish and zebrafish liver was determined following a 
protocol previously developed in our laboratory258. Briefly, total lipid content was extracted 
following the Folch lipid extraction method259 with some modifications. Samples were 
homogenised with a pellet pestle (ultra turrax, Ika), and lipids were extracted using 2:1 
chloroform:methanol solution partitioned with water, followed by phase separation, organic 
phase collection, dehydration and evaporation. Lipids were weighed and re-suspended in 
organic solvent (2:1 chloroform:methanol) to a final concentration of 1 mg/mL. Fatty acid 
identification was performed using gas chromatography analysis. Lipids were directly 
transesterified to generate FAMEs for detection by GC-FID. Analysis was performed using a gas 
chromatographer (Agilent 6850) equipped with a FID. Separation was performed in a 30 m x 
250 μm x 0.25 μm column (DB-WAX, Agilent, USA). FAMEs were identified by comparison with 
cis and trans FAME standard retention times (Sigma). FAMEs were estimated as percentages 
relative to total peak area. 
 
3.5. Microbiome analysis 
Total DNA from the same 24 intestinal samples used for RNA extraction was extracted 
using Trizol Reagent (Invitrogen) according to the manufacturer’s instructions. DNA 
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concentration and purity were analysed measuring the absorbance at 260nm and A260/A280 
ratio respectively with a Nanodrop (Thermo). 
The microbial community composition of 8 fish per treatment (n=8) was characterised 
by sequencing the V3-V4 16S rRNA region using the primers S-D-Bact-0341-b-S-17 and S-D-
Bact-0785-a-A-21155 in an Illumina Miseq Platform. Paired reads were merged using FLASH156 
after removing primer sequences with Trimmomatic. The rest of the bioinformatic analysis was 
performed using the Qiime (Quantitative Insights Into Microbial Ecology) software package 
(v.1.9.0)50. Sequences were clustered as operational taxonomic units (OTUs) of 97% similarity 
using UCLUST260. OTUs were checked for chimeras using the RDP ‘gold’ database and assigned 
taxonomy using the Greengenes database (version 4feb2011)261. Alpha diversity indices 
(Number of observed species, Chao1 and Shannon index) were calculated using the QIIME 
pipeline and displayed in R. Beta diversity metrics were analysed by weighted UniFrac and 
visualised in a principal component analysis plot (PCoA). The significances of grouping in the 
PCoA plot were tested and Analysis of Similarity (ANOSIM) with 999 permutations was 
employed. The significant fold changes of OTUs were performed in DESeq2 R package262. 
Pearson correlations among gut microbiota (OTUs that significantly differed among diets), the 
composition of the whole fish lipid profile, gene expression, and fat percentage were calculated 
and displayed in R (ggplot2 and corrplot packages).  
In the current study, PICRUSt was used to obtain an overview of the metabolic features 
of the bacterial communities in zebrafish which had been fed experimental diets. The OTUs 
were associated with known bacterial genomes pre-calculated in PICRUSt, by first picking 
closed OTUs against the Greengenes 16S rRNA gene database (13.5) using QIIME263. The 
resulting OTU table was then normalised using the script normalize_by_copy_number.py and 
used for metagenome inference of Kyoto Encyclopedia of Genes and Genomes (KEGG) Orthologs 
using PICRUSt. The difference in the predicted molecular functions of the bacterial communities 
was determined by Welch´s t-test using the Statistical Analysis of Metagenomic Profiles 
(STAMP) software package264.  
In addition, raw sequences were deposited in the European Nucleotide Archive (ENA) 
under the project number PRJEB24592.  
3.6. Gene expression analysis 
Total RNA from the intestines and livers of 8 zebrafish per treatment (n=24) was 
extracted using Trizol Reagent (Invitrogen) according to the manufacturer’s instructions. The 
quantity and quality of RNA samples were determined by capillary electrophoresis using an 
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Agilent 2100 Bioanalyzer (Agilent Technologies). Only RNA samples with a RIN of at least 8.5 
were used. These values fulfil one of the requirements of a satisfactory qPCR experiment211. 
cDNAs were synthesised from the RNA samples in a reverse transcription reaction 
performed with TaqManTM reverse transcription kit (Applied Biosystems) containing 20 ng of 
RNA per assay. Changes in mRNA expression of genes related to the innate immune system 
(ASC, CASP1A, IL-1Β, IL10, IL22 TNFA, NFKB, MYD88, MMP9, MPO and NOD1), host-microbe 
interaction (TLR4, TLR5, TLR22, DEF1 and MUC2), metabolic activity (IAP), insulin growth 
factors (IGF1 and IGF2) and lipid metabolism (FAS and PPARg) were monitored by real-time 
qPCR using β-actin (ACT) and elongation factor 1 (EF1) as reference genes to normalised the 
results, as previously described in chapter 3. Primer sequences are listed in chapter 3 and 
supplementary material Table 3. 
 
3.7. Statistics 
Data are expressed as means +/- SEM. The p-values were calculated with a T-test and 
ANOVA test, using the software Statgraphics v16.1.17 (StatPoint Technologies, Inc.) and SPSS 
version 3.4 (IBM). All p-values were adjusted via Bejamini Hochberg correction219 or false 
discovery rate (FDR). A p value < 0.05 was considered statistically significant.  
 
4. Results 
4.1. Effect of experimental diets on zebrafish glucose and lipid profile 
At the end of the experiment, fish blood glucose levels were measured. Although no 
significant differences were identified, blood glucose levels tended to be higher in HFD samples, 
whereas in samples fed with HFO they tended to decrease. In addition, total body fat percentage 
(per weight) tended to increase in HFD- and HFO-fed animals compared to the control group.  
In the current study, the fatty acid profiles of liver and whole fish fed with different diets 
was analysed by FAMEs (Table 2). A significantly increased level of palmitic (16:0) and stearic 
acids (18:0) was observed in HFD-fed animals compared with the control diet (20.7 versus 
19.3% of palmitic and 10.3% versus 3.9% of stearic respectively, p < 0.05). In contrast, palmitic 
acid decreased in HFO-fed animals (17.8%, p < 0.01). The most abundant monounsaturated 
fatty acid (MUFA), oleic acid (16:1), was augmented by 55% in the HFD group compared to the 
control (17.2 versus 32.2, p < 0.01), while in the HFO samples it was 13% lower (27.9, p < 0.05). 
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For PUFA detected in whole fish, linoleic (18:2) and alpha-linoleic (18:3) acids accumulated in 
the HFD group (p < 0.01), while EPA (20:5) and DHA (22:6) fell by 1.6 and 1.4 times, respectively 
(p < 0.01). Conversely, EPA and DHA levels rose in HFO-fed animals 1.3 and 1.8 times 
respectively (p < 0.01).  
Thus, the total SFA and MUFA were augmented in HFD-fed animals compared to control 
animals (32.5% versus 26.6%, and 36% versus 23.8%, respectively, p < 0.01), whereas animals 
fed HFO exhibited reduced levels (29.6% and 31.2%, respectively, p < 0.01). Interestingly, the 
total levels of PUFA and EPA + DHA were much lower in the HFD group (30.4% versus 48.2% 
and 10.34% versus 15.7% respectively, p < 0.01). In HFO samples PUFA rise (36.9% and 18.1% 
respectively, p < 0.01) (Figure 29).  
In the liver, the only incremented SFA and MUFA in the HFD samples, compared to the 
control, were stearic (9.1% and 4.5% respectively, p < 0.05) and oleic (17%, 7.9% respectively, 
p < 0.05) acids, which, in contrast, decreased in the HFO group (6.3% and 8.1% respectively, p 
< 0.05). In PUFAs, DHA only changed in HFO-fed fish comparing to HFD, increasing its level 
(1.5% and 0.8% respectively, p < 0.05). Finally, the total PUFA content in HFD and HFO samples 
changed significantly, diminishing 1.25 times in HFD and conversely, increasing 1.26 times in 
HFO (p < 0.01). Results are summarised in supplementary material table 4. 
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Figure 29. Effects of HFD and HFO on fish. A: total fat percentage, B: glucose level in blood and 
C: relative proportion of SFA, MUFA and PUFA, for the experimental diet groups (control, HFD, 
HFO) * represents statistically significant differences between control and HFD (p < 0.05), whereas 
* represent differences statistically significant between HFD and HFO (p < 0.05). 
 
4.2. Changes in the intestinal microbial community in response to the 
high-fat diet and DHA supplementation 
After 6 weeks of 3 different dietary interventions, the DNA from the intestine of 8 fish 
per diet (n=24) was extracted and sequenced by 16S RNA tagging for analysis of the gut 
microbial community. A total of 1639702 sequences of the V3–V4 region of 16S rRNA were 
collected from the 24 intestinal samples, of which the median sequence number was 72322 
(25857 SD). All the sequences were clustered into 1402 OTUs at a 97% similarity level. The 
Venn diagram shows that 50% of the OTUs (699 OTUs) were common to all three diets (Figure 
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30 A). However, 11% of the OTUs (160 OTUs) were found only in HFD-fed groups (HFD and 
HFO), and 2% (28) corresponded to OTUs present only in the DHA-supplemented group (HFO). 
The changes in bacterial richness (expressed by SOBS and Chao1) and diversity 
(expressed by the Shannon index) in response to the HFD and HFO diets were analysed. None 
of the diversity indices tested indicated significant change. These results suggest that the 
consumption of HFD and HFO did not affect the alpha diversity of the community (Figure 30 B). 
However, as demonstrated by unweighted UniFrac analysis of beta diversity, different sample 
clustering was observed between diet groups (ANOSIM p=0.001). This means that the 
consumption of a HFD changed gut microbiota composition significantly compared to the 
control group (ANOSIM Control-HFD p<0.001). In addition, there is a significant effect on the 
microbiota in response to DHA supplementation compared to HFD (ANOSIM HFD-HFO 
p<0.001) (Figure 30 C). 
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Figure 30. Alpha and beta diversity index. A: Venn diagram showing the unique and shared 
distribution of OTUs of control (red), HFD (blue) and HFO (orange) groups. B: SOBS and Chao1 
index as estimators of the gut microbiota community richness, and Shannon index as community 
diversity estimator. C: Principal component analysis (PCoA) score plot based on unweighted 
UniFrac distance of control (red squares), HFD (blue dots) and HFO (orange triangles) (p< 0.001). 
 
At phylum level, the most abundant phyla in all samples were Fusobacteria (45.5%, 
44.5% and 64.5% in control, HFD and HFO samples, respectively), Proteobacteria (37.2%, 50% 
and 30.5%), Cyanobacteria (14%, 1.2% and 2.8%) and Tenericutes (1.8%, 3.1% and 1%) (Figure 
31 A). At family and genus level significant differences were observed among the diets. 
Pseudomonadaceae increased in the HFD (0.8% vs. 26.7% in control and HFD samples, 
respectively) (p<0.05). In contrast, Tenericutes CK-1C4-19 decreased (1.6% and 0.1%, 
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respectively) (p>0.05) (Figure 31 B). At genus level, the most important changes were found in 
Pseudomonas, Acinetobacter and Tenericutes ck1c4-19. Pseudomonas and Acinetobacter 
significantly increased (p<0.03) (from 0.8% to 26.6%, Pseudomonas, and from 0.001% vs. 0.1%, 
Acinetobacter) with the consumption of a HFD. Conversely, Tenericutes ck1c4-19 decreased 
(p<0.05) (from 1.6% to 0.1%). As a result, in the HFO group Pseudomonas and Acinetobacter 
tended to decrease (5.1% and 1% respectively), whereas Tenericutes ck1c4-19 increased (1%) 
(Figure 31 C).  
 
 
Figure 31. Differences in relative abundance. A: Pie chart representing the relative abundance 
of phyla in animals fed a control diet and the HFD and HFO. Stacked bar chart representing the 
mean in control and HFD B: families and C: genera. 
 
In order to identify the specific bacterial taxa differentially affected by HFD and DHA 
supplementation, the significant fold-change at OTU level was calculated. Based on this analysis 
97 OTUs were identified as key phylotypes responsible for the differences among the dietary 
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groups (Figure 32 A). In particular, HFD samples were enriched by 17 OTUs affiliated to 
Pseudomonas, 3 to Shewanella and 1 to Acinetobacter. In contrast, 1 OTU affiliated to Tenericutes 
CK-1C4-19, 24 to Stramenopiles, 23 to Rhodobacter, 2 to Plesiomonas shigelloides, 3 to Legionella 
and 2 to Agrobacterium were down-regulated in HFD-fed animals (Figure 32 B). When HFD was 
co-supplemented with DHA, 11 out of 17 Pseudomonas-affiliated OTUs, and one of the OTUs 
affiliated to Legionella decreased. In contrast, the unique OTU affiliated to Tenericutes increased 
in HFO. In addition, an increasing tendency was observed in OTUs affiliated to Hydrogenophaga 
and Plesiomonas shigelloides in HFO samples (Figure 32C). 
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Figure 32. Differences in OTU composition. (A) Heatmap comparison based on the relative 
abundance of 97 key phylotypes identified from the experimental diets. OTUs were significantly 
different (q < 0.1 FDR) between control and HFD-fed-animals. B: Upper axis represents OTUs with 
a log2 fold positive difference for control relative to HFD while the lower y-axis is the negative fold 
difference of the control relative to HFD C: the difference of HFD compared to HFO. Each point 
represents a single OTU coloured by phylum and grouped on the x-axis by taxonomic genus level, 
size of point reflects the log2 mean abundance of the sequence data. 
 
4.3. Microbial community predictive functions 
The results of the predicted metabolic functions of the microbial communities were 
analysed in PICRUst using level 3 categories. In animals fed the HFD, three pathways involved 
in amino acid metabolism, ABC transporters, and glutamatergic synapse were more dominant 
(Figure 33 A). Whereas for animals fed HFO, pathways concerning adiponectin signalling, 
transporters, lipid metabolism including linoleic and arachidonic acids and ABC transporters, 
and tryptophan metabolism were more prominent. Pathways related to the synthesis of ketone 
bodies, lysine-arginine-proline metabolism, bacterial chemotaxis, N-glycan biosynthesis, and 
peptidoglycan metabolism were regulated in an inverse manner in both HFD and HFO animals, 
suggesting a beneficial effect of DHA on those pathways (Figure 33 B). 
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Figure 33. PICRUST. Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 
of A: control vs HFD and B: HFD vs HFO samples. The mean proportion of each inferred metabolic pathway 
is represented in bars. The difference in mean proportion and the p value are also represented. 
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4.4. The effect of experimental diets on immunity 
The expression of 19 genes related to the zebrafish immune system were analysed from 
the intestines of 8 individuals per treatment by qPCR. Additionally, genes associated with 
inflammation and with lipid and glucose metabolism were tested in 8 livers per diet group. 
None of the genes tested changed its expression in response to the experimental diets, 
suggesting that the HFD did not induced inflammation in zebrafish adults (Figure 34). 
 
Figure 34. Gene expression fold change analysis after 6 weeks of diet exposure in control, 
HFD and HFO groups in A: intestine and B: liver. Error bars indicate the standard error of the 
mean. 
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4.5. Correlation between fatty acids and microbial changes 
OTUs that significantly differed among diets were correlated with the fatty acid profiles 
of whole fish calculated using Pearson correlation analysis (Figure 35) The heatmap shows 
significant correlations among OTUs affiliated to Pseudomonas, Acinetobacter, Shewanella, 
Plesiomonas and Tenericutes CK-1C4-19 with the fatty acids related to different diets.  
In the HFD-fed group, the increase of cocoa butter fatty acids (stearic, palmitic and oleic 
acids, SFA, and MUFA) and the decrease of PUFA, omega-3 and EPA+DHA was correlated with 
the augmentation of Pseudomonas- and Acinetobacter-affiliated OTUs, and in contrast, with the 
reduction of Tenericutes CK-1C4-19 and P. shigelloides OTUs. Interestingly, Pseudomonas 
OTUs were also positively correlated to the increase in blood glucose. In addition, 2 OTUs 
assigned to Shewanella were enriched in HFD samples, whereas 3 OTUs decreased. As in the 
groups mentioned above, both changes were correlated with the fat content. Conversely, the 
HFO-fed group exhibited a decrease in Pseudomonas, and an increase in Tenericutes CK-1C4-
19 and 2 Shewanella OTUs, which correlated with the enrichment of PUFA, omega-3 and 
EPA+DHA, and with the reduction of cocoa butter fatty acids. Glucose level also correlated 
positively with the decrease in Pseudomonas in these samples. 
The decrease in the relative abundance of Rhodobacter, Hydrogenophaga, Plesiomonas, 
2 OTUs affiliated to Shewanella, and Legionella was not correlated with changes in the lipid 
profile. 
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Figure 35. Correlation plot showing Pearson correlations between fatty acid lipid profile and 
key phylotypes. Blue dots are positive correlations, whereas red dots are negative correlations. 
Dot size is determined by the correlation grade. Only significant correlations are represented (p < 
0.05). 
 
4.6. Correlation between fat and gene expression 
The differential expression of genes in the intestines and liver were compared to whole 
fish and liver lipid profiles in order to examine any correlation. Interestingly, the increase of fat 
in HFD samples was positively correlated to the increase of TLR 2 and 4 expression. However, 
in HFO samples, there was a positive correlation between the decrease of stearic acid and TLR 
2 and 4 expression. In addition, in the liver, a negative correlation was observed between 
omega-3 liver parameters (C 22:6, total omega-3, and EPA+DHA ratio) and FASN (fatty acid 
synthase), NFKB and MYD88 genes tested in the HFD group (Supplementary Material Figure 3). 
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5. Discussion 
It is widely accepted that diet alters the gut microbiota diversity in humans and other 
animals265. In this chapter the ability of two experimental diets to induce changes in intestinal 
microbial composition, the immune system, fatty acid lipid profiles, and metabolic functions in 
adult zebrafish was investigated. HFD was formulated by enriching the fat content with cocoa 
butter (20%), composed of SFA and MUFA, as it has previously been demonstrated that 20% 
fat-increased HFD induces obesity, body fat accumulation and intestinal dysbiosis in 
zebrafish146,121. In contrast, the HFO diet was supplemented with a commercial fish oil in a 
concentration previously described as effective in zebrafish266. Diets rich in omega-3 have been 
shown to positively influence host health by maintaining microbial homeostasis in humans249, 
enriching beneficial bacteria, and reducing other microbes. However, the bacterial phylotypes 
affected by the effect of omega-3 and the mechanism are not yet understood250. 
Numerous studies have demonstrated that the consumption of a HFD leads to intestinal 
microbial dysbiosis190 251, altering the community composition and reducing the diversity32.In 
our study, no significant changes in community richness or evenness induced by the 
experimental diets were observed. This result is in agreement with Wong et al.121, who did not 
report changes in alpha-diversity at any age in zebrafish fed a HFD (20% fat-enriched). 
Conversely, they relate community membership changes from 35 dpf to adulthood with dietary 
fat, as occurred in our study. In the results of our experiment, the PCoA plot showed a clear 
separation of control, HFD and HFO dietary groups suggesting that dietary fat content exerts an 
effect on the intestinal microbial community. Furthermore, our results indicate that fish oil 
supplementation may induce a positive effect on the microbial dysbiosis provoked by HFD 
consumption. 
Besides changes in the overall gut microbial community structure, HFD consumption 
induced microbial alterations at different taxonomic levels. The dominant phyla for all diets 
were Fusobacteria and Proteobacteria in zebrafish adults, as previously described122. However, 
the difference in the source of fat chosen to formulate the HFD, the age of the fish, and the 
microbial community of the facilities make it difficult to compare our results directly to other 
studies that described zebrafish microbial changes induced by other formulations of HFD.  
Ninety-seven specific bacterial taxa altered by the HFD and modulated by fish oil 
supplementation were identified. In addition, this change correlated with changes in host lipid 
profile and immunity. An increase in OTUs affiliated to Acinetobacter, as previously described 
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in obese human individuals consuming a HFD267, and Pseudomonas was observed in HFD 
samples in zebrafish. Pseudomonas are widely distributed, constituting a part of the normal 
microbiota of the aquatic environment268. They are part of zebrafish core microbiota125, 
occurring in an abundance of 0-2% in normal conditions of domesticated zebrafish, as in our 
control group. In a HFD environment, Wong et al. also found Pseudomonas OTUs were more 
abundant121. Additionally, the increase in both taxa was positively correlated with the increase 
in fat and cocoa butter fatty acids, and with the decrease of omega-3 related fatty acids. 
However, in HFO samples the fish oil exerted a positive effect on Pseudomonas’s relative 
abundance, which correlated with the decrease in cocoa butter fatty acids and the increase in 
omega-3. A previous study corroborated the positive effect of a commercial omega-3 
supplement on the growth of Pseudomonas aeruginosa in Galleria mellonella, a caterpillar 
model, and mice269 270. Dietary control of Pseudomonas by modulating omega-3 intake could 
represent an interesting target in nosocomial infections caused by this taxa, as some species are 
described as highly resistant, and frequently escape eradication by antibiotics, constituting a 
serious problem271.  
The HFD also produced an effect of reducing the relative abundance of Tenericutes CK-
1C4-19, P. shigelloides, Stramenopiles, Legionella, Rhodobacter and Hydrogenophaga-related 
OTUs. Increases in P. shigelloides, Rhodobacter and Legionella have previously been associated 
with microbial changes due to the consumption of a high-protein diet (HPD) and a gluten-rich 
diet in zebrafish140, 141. Interestingly, Koo et al. reported that these changes were associated with 
a gluten rich diet, which contained less fat than the control, thus supporting our results140. 
Furthermore, Rurangwa et al. found that HPD-fed zebrafish positively associated with an 
increase in protein biosynthesis and amino-acid transport47. In our HFD group the digestion 
and absorption of carbohydrates and peptidase activity were reduced in comparison to the 
control group, in contrast to what occurred with HPD and gluten diets. In addition, changes in 
the above taxa did not directly correlate with the effect of dietary fat. This could be explained 
by the influence exerted by increases in microbes in response to a HFD. The intestine is a 
dynamic ecosystem where environmental changes result in microbial ecological niches driving 
shifts affecting the microbiome composition. The interactions between the microbiota and the 
niche environment are complex and diverse, but they are generally deterministic7. The increase 
in fat in the intestine favours the increase of Pseudomonas, in consequence reducing the relative 
abundance of other taxa, such as those mentioned above, and therefore modifying the gut 
environment. Bacterial interference occurs via exploitative competition where one organism 
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consumes the available resources, or via direct competition, characterised by an active 
secretion of competitor molecules (siderophores, secondary metabolites, or toxins)272.  
The relative abundance of the inferred functional capacities of the microbial 
communities showed that different pathways related to bacterial interactions were affected by 
the diets. Lysine, arginine and proline metabolism and siderophore biosynthesis were up-
regulated in the HFD group. These pathways might be associated with Pseudomonas metabolic 
activity, which usually produce two siderophores, pyoverdine and pseudobactin, conferring 
them with a higher capacity to colonise and compete with the other microorganisms of the 
niche273. In addition, a bacterial chemotaxis pathway, previously associated with the bloom of 
Proteobacteria in mice274, and pore ion channels were over-expressed in HFD-fed animals. This 
suggests that bacterial movement and communication skills may provide a growth advantage 
to Pseudomonas, which has the ability to form biofilms275. Conversely, the N-glycan biosynthesis 
pathway exhibited lower expression in HFD-fed animals, as previously found in obese children. 
In humans, N-glycan biosynthesis disorders are associated with metabolic diseases276. In HFO-
fed animals, the bacterial chemotaxis pathway was down-regulated, whereas N-glycan 
biosynthesis was increased, suggesting a beneficial effect of the fish oil in modulating bacterial 
interactions.  
In summary, the results suggest that dietary fat causes changes in the intestinal 
environment, enhancing the growth of Pseudomonas and Acinetobacter and reducing the 
abundance of other taxa. This change involves the augmentation of bacterial metabolism, which 
may enhance the growth and expansion of Pseudomonas and reduce the resources of the niche 
which are needed for the maintenance of the other microbes, such as Tenericutes CK-1C4-19, P. 
shigelloides, Stramenopiles, Legionella, Rhodobacter and Hydrogenophaga. Fish oil 
supplementation seems to alleviate these effects by decreasing the relative abundance of 
Pseudomonas and increasing Tenericutes CK-1C4-19 and Legionella, thus helping to maintain 
intestinal homeostasis.  
In addition, in the HFD-fed group, the increment in animal fat content correlated with the 
up-regulation of TLR2 and 4 expression in the intestine, even though they were not 
overexpressed. TLR 2 is typically bound by gram-positive bacteria, whereas TLR4 is activated 
by gram-negative. It is well known that the increase of gram-negative bacteria, such as 
Pseudomonas in our experiment, in response to a HFD may increase the expression of these 
receptors, activating an inflammatory response. However, dietary fats are also able to induce 
the expression of those two receptors, as mentioned in chapter 3, specifically stearic and 
palmitic acids. Additionally, TLR4 can be also activated by lauric acid277. All these acids are 
Chapter 4 
 
105 
components of the cocoa butter used to formulate the HFD. It is known that SFAs trigger 
inflammation activating MyD88 adaptor protein which induces activation of NF-κB277, whereas 
omega-3 and omega-6 are potent TLR4 inhibitors278. In the HFO-fed group, the presence of fish 
oil decreased the stearic acid level, which correlated positively with the decrease of TLR 2 and 
4 expression. Interestingly, the expression levels of NFKB and MYD88 in the liver were 
negatively correlated with the increase of DHA in HFO samples. In addition, functional 
capacities for omega-6 metabolism were lower in HFO samples. The activity of linoleic and 
arachidonic acid metabolism depends on the omega-6/omega-3 ratio, so this indicates a 
positive effect on omega-3 increment induced by the fish oil. This result suggests that fish oil 
intake decreases inflammatory cytokine production by inhibiting the activation of NF-κB279. 
Dietary changes in the intestinal environment favour the increase of Pseudomonas and specific 
SFA, which are able to induce TLR 2 and 4 expression. Fish oil may exert a beneficial effect on 
inflammation. As no inflammation was observed in this experiment more research is needed to 
clarify this question.  
In the liver the expression of IGF2, and FASN, correlated negatively with the increase of 
DHA in the HFO group. IGF2 is a hormone associated with insulin and glucose uptake whose 
overexpression has been related to obesity and diabetes280, whereas FASN relates to lipogenesis 
in hepatic tissue281, and this expression level did not change in previous studies performed in 
adult zebrafish282. Functional pathways regulating lipid metabolism, obesity and diabetes were 
suggested to differentially express in HFD and HFO groups. In HFD samples metabolism related 
to transport, biosynthesis and degradation of branched-chain amino acids (BCAA) and ketone 
bodies, was heightened. ABC transporters, whose metabolism was increased, are essential for 
the maintenance of cell and tissue homeostasis as they drive the exchange of nutrients and 
metabolites, such as hormones, amino acids, ions, vitamins and lipids283. These transporters 
have been found to be overexpressed in obese Chinese children and adolescents276. Rurangwa 
et al. also correlated the heightened expression of transport metabolism in response to diet with 
the activation of immune response in zebrafish141. The up-regulation of the biosynthesis and 
degradation of BCAA (leucine, isoleucine and valine) and ketone bodies may play a role in 
obesity and diabetes in humans and rodents284,285. Fish oil may help to reduce this effect, as we 
found that BCAA metabolism was down-regulated in the HFO group. Previous studies in mice 
suggested that the reduction in isoleucine levels promote lipolysis via induction of lipolytic 
genes and by the suppression of lipogenesis in the liver286. Finally, in HFO samples 
adipocytokine signalling, related to adiponectin release which has anti-obesogenic and anti-
diabetogenic properties, was increased, as previously described287. These results suggest that 
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changes produced in the intestinal microbiome by the HFD are associated with obesity and 
diabetes metabolic pathways. In contrast, fish oil supplementation seems to contribute to 
reverse this effect. 
In recent years microbes have been increasingly recognised as having an important role 
in brain development and behaviour288. In the current study metabolic pathways associated 
with the homeostasis of the gut-brain axis have also been affected by HFD and fish oil 
supplementation. Glutamatergic synapse signalling, whose alterations may play a role in the 
acute regulation of food intake and energy balance289, was up-regulated in HFD samples. In 
contrast, tryptophan metabolism was reduced in HFO samples. This metabolite participates in 
serotonin release, whose biosynthesis in the brain is regulated by gut microbiota290. This 
neurotransmitter is an important gastrointestinal regulatory factor, as its dysregulation has 
been associated with several diseases in human such as intestinal bowel disease and 
cardiovascular disease290. This suggest, that the microbial changes due to a HFD affect functions 
in other organs beside the intestine, where the microbiota plays a defined role. However, fish 
oil may palliate these effects. 
 In conclusion, this research supports that the HFD feeding in zebrafish adults induces 
a negative effect on intestinal environment. These environmental alterations exert changes in 
the intestinal microbial community favouring the increase of Pseudomonas and Acinetobacter. 
The augmentation of these taxa induces the reduction of other microbes thus losing diversity 
and affecting the intestinal homeostasis. The intestinal microbes and the dietary fatty acids are 
able to bind the enterocytes TLR, activating the inflammatory response that characterised 
obesity. Furthermore, the bacterial metabolism which favours lipid transport, obesity, insulin 
release and gut-brain axis mediation are up-regulated by the HFD consumption. In contrast, it 
was demonstrated that the HFD supplementation with fish oil may exert a beneficial effect on 
these changes alleviating the negative impact induced by the HFD. 
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The zebrafish is a model organism widely used for basic research in multiple fields of 
study. In microbial research, it has been used to understand the pathogenesis of diverse 
microorganisms and interactions of microbes, such as pathogens vs probiotics137. The optical 
transparency of embryos and larvae constitutes a distinctive feature of zebrafish, allowing the 
visualisation of bacteria in vivo, previously labelled with fluorescence. It is also interesting to 
work with transgenic lines to observe the interaction of pathogens with the immune system. 
Moreover, from our perspective, this model allows us to go further than has previously been 
possible. 
To determine the possible use of zebrafish as a feasible model for the study of host–
microbiota interactions, two different types of study have been proposed herein. The first 
aimed to shed light on the possibility of human microbiota transplantation into GF zebrafish as 
a recipient, describing which species of the human flora are able to colonise the zebrafish 
digestive tract. The second was performed to gain an in-depth understanding of the impact of 
diet on the host and its intestinal microbiota. 
In the first chapter of this thesis, a colonisation protocol was developed maintaining 
sterility and anaerobiosis. The success of this part was crucial for the subsequent studies 
because at that point all the colonisation approaches reported by other studies failed149. Our 
colonisation protocol was based on static immersion, a technique easier to carry out than 
microinjection. Toh et al. did not report differences in terms of colonisation success using the 
two techniques, recovering only 2 out of 30 strains used in the experiment inside the zebrafish 
digestive tract149.  However, using our protocol, all the strains included in the study, which 
contained not only facultative anaerobes but also obligate anaerobes, were identified inside the 
zebrafish gut at 48 hpi.  
It has previously been reported that facultative anaerobes are able to colonise and grow 
inside the zebrafish gut, occupying almost all the niche space and resources9. For this reason, 
Toh et al. decided to limit such microorganisms in their experiment149. In addition, the bacterial 
species proposed in both, Toh et al.’s experiment and our experiment are not a part of the 
normal flora of zebrafish, which may cause difficulty for their establishment and colonisation 
success in this hostile environment. For this reason, we tested the colonisation protocol not only 
in consortium, but also with each bacterial strain separately (monoassociation). In consortium, 
although all the strains included in the study were found inside the zebrafish intestine tract, in 
general monitoring showed lower counts. Facultative anaerobes in this consortium, such as E. 
coli and E. faecalis, were able to establish and grow with time, whereas the growth of the 
obligate anaerobes, E. limosum and B. breve, decreased and finally disappeared. The bacterial 
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interspecific competition for the niche resources might act as a limiting factor. In contrast, in 
monoassociation, the absence of interspecific competition allows the colonisation of the 
zebrafish gut, presenting higher counts for all the strains.  
Taking into account these promising results, we designed the study presented in the 
second chapter. There, the purpose was to determine which human microbiota phylotypes 
were able to colonise the digestive tract of the zebrafish larvae. This objective represented a 
great challenge because, as far as I know, no-one has previously published these useful data. To 
date, previous studies transplanting mice intestinal microbiota into GF zebrafish larvae only 
recovered facultative anaerobes inside the output community9. As previously described, 
differentiated parts of the digestive tract, tissue cell types and microbial colonisation and 
functions are highly conserved from zebrafish to mammals. These features might make 
zebrafish a suitable model for the transplantation of human flora. Here we demonstrated that 
up to 60 human intestinal bacterial phylotypes, representing 2% of the OTUs present in 
humans, were able to colonise the digestive tract of GF zebrafish larvae.  
One of the limitations encountered in achieving better colonisation results was the 
zebrafish intestine as a niche itself. Even though the structure and cell types are conserved, the 
length and size are very small in zebrafish. For this reason, the high microbial load present in 
the human slurry inoculum needed to be diluted to carry out the colonisation, losing microbial 
taxa in the dilution process. In addition, the niche environmental factors, such as oxygen 
concentration and temperature, are also distinctive features which interact with the microbes 
shaping the final community9. Microbial activity also plays an important role in the colonisation 
process. As a result, E. coli is able to multiply in the zebrafish gut, reaching the 95% of the counts 
in 48 h, whereas the relative abundance in the inoculum was 0.1%. Escherichia coli is a 
ubiquitous bacterium able to persist and replicate in water and soil environments. Thus, it is a 
faecal indicator of water quality291. An important strategy in our infection protocol that others 
have not reported was the enrichment of the larvae medium with vitamins and other 
ingredients to favour the growth of fastidious microorganisms. However, while these microbes 
might take advantage of these resources, other bacteria may also use them to grow more. The 
excessive growth of E. coli may lead to ecological resource consumption and space invasion, not 
permitting the establishment of other microbes which grow slower. Finally, not only are 
environmental factors important in an ecosystem, but also microbe–microbe interactions are 
decisive and unfortunately uncontrollable in most cases.   
An alternative solution to this problem might be larvae feeding, allowing the entry of 
nutrients to the intestinal ecosystem and avoiding food limitation. However, the best option for 
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eradicating this difficulty would be E. coli growth limitation. Phage therapy is a very specific and 
safe technique which may help to control E. coli proliferation292. Furthermore, the lytic action 
of phages is completed in a few hours.  
Despite all these limitations, humanised zebrafish might be used to study processes that 
do not extend over time. In addition, with knowledge of the species that are able to colonise the 
zebrafish gut, different SIHUMIs may be created. Furthermore, simplified models might be also 
used as a mock community for sequencing. 
Another point of interest in this thesis was the study of host–microbiota interactions. As 
a matter of fact, we deepen into the knowledge of this fact in the third and fourth chapters. The 
humanised model did not allow experiments extended over time due to the complexity of the 
maintenance of stable microbiota and the axenic environment. Therefore, it was decided to 
continue the study with conventional zebrafish microbiota. The importance of the functions of 
the microbiota for the host, its modulation by diet and also the similarities of the zebrafish 
immune system to that of humans might make zebrafish a suitable model for studying host–
microbiota interactions, although the microbiota in terms of species is different135. 
The obesity is considered the 21th century pandemic. For that reason, in our point of view 
understand the mechanisms underlying this metabolic disease it is highly important. HFD 
consumption lead to obesity in zebrafish and humans, related to the intestinal microbiota 
dysbiosis and inflammation265. Lipid metabolism and immune system pathways are also 
conserved between zebrafish and mammals. Therefore, here we studied the intestinal microbial 
community, and immune system modulation by the consumption of a diet rich in fat in zebrafish 
larvae and adults.  
As previously described, the microbiota of zebrafish larval and adult stages differs in 
composition and are therefore not comparable. This has already been described by Wong et 
al.121,  demonstrating that the diversity of the microbiota in the larval stage is greater than in 
adulthood. In relation to this, in the third and fourth chapters, we also observed that the 
microbiota composition at taxonomic levels at both ages was different (Figure 36). The 
microbiota of the larvae is dominated by Proteobacteria and Firmicutes. In contrast, in the 
adulthood Fusobacteria is the predominant phylum, followed by Proteobacteria and 
Cyanobacteria. In larval samples greater number of OTUs than in adults were identified. In 
addition, of all the OTUs presented in both samples, only 37 are shared between both states, 
which is called "core microbiota"125 (Figure 36). 
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Figure 36. Relative abundance at phylum and genus level in adult and larval control sample and 
Venn diagram showing the number of OTUs in adult and larval control samples and OTUs shared 
between them. 
 
The consumption of a HFD did not change alpha diversity neither in larvae nor in adults. 
This, could be explained by the changes produced by the diet not being as pronounced as in 
other cases such as in an IBD, in which some taxa disappear and therefore there is a significant 
loss of diversity293. 
As previously mentioned, the larvae microbiome resembles the environment because it 
is nourished by the environmental microbiota121. In addition, the immune system is not 
completely developed, as the adaptive immune response is not completely formed until 6 
wpf223. Thus, as seen in chapter 3, changes in the microbiota in the larval stage induced by the 
consumption of the HFD, led to the immune response activation via the canonical NF-κB 
pathway. In addition, a host response to protect the intestinal barrier was also detected by the 
secretion of AMP and the increase of goblet cells. The transparency of the zebrafish embryo and 
larvae allows whole-mount microscopy, which is one of the main advantages for carrying out 
the studies at larvae state97. Moreover, zebrafish spawning produces a high number of embryos, 
however, many of them die in the first month of life. For that reason, the larvae maintenance is 
more delicate than in adulthood. In addition, it is difficult to surgically remove the organs, and 
in most of cases it is necessary to make pools to obtain the quantity of tissue needed for the 
subsequent analysis. 
The HFD in this thesis, for both larval and adult experiments, was formulated by adding 
cocoa butter to the diet recommended for each developmental stage. This ingredient was 
concretely chosen due to the high content of SFA and MUFA and the relationship of its fatty 
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acids with obesity220. It is more difficult to carry out dietary studies with fish than with mice 
because in the aquatic environment the dose that each individual eats cannot be controlled. For 
that reason, the study of the lipid profile that we carried out in the fourth chapter of both, diet 
and animals is of importance to identify which fatty acids are responsible for the changes 
identified. However, there are some limitations in carrying out this technique in larvae since a 
huge amount of fat is needed and therefore a large number of individuals258. Thus, it has only 
been carried out in adults.  
In adults, the control diet contained higher percentage of fat than in the larvae. Although 
the manufacturer does not detail the fat composition, the lipid profile analysis shows that the 
fatty acids that compose this diet are especially SFA and MUFA. The manipulation and 
maintenance of adults, are simpler than in larvae. Additionally, the extraction of all the organs 
is feasible, thus obtaining several samples for the same individual with enough tissue to analyse 
each individual separately and to correlate changes in different organs. In this study no 
inflammation associated with microbial changes was detected in adults. This result might be 
due to that fish could already be inflamed because of the high content of saturated fats in the 
normal diet that the fish had been eating throughout their adult stage. To clarify this issue, it 
would be desirable to carry out the experiment with fish that have been fed a quality diet from 
the juvenile stage. Nevertheless, this would extend the experiment over time. Although no 
inflammation was observed, the increase in SFA and MUFA derived in intestinal environment 
and microbial changes. In fact, the heightening in saturated and monounsaturated fatty acids in 
both the diet and the fish represented important changes in the microbial community and 
correlated to TLR expression. The growth of some taxa and the increase in cocoa butter fatty 
acids (stearic and palmitic acid) in the intestine correlated with TLR2, 4 and NFKB expression. 
This suggests that there is an activation of these receptors and the NF-κB-mediated 
inflammatory pathway with the microbial changes and dietary fatty acids. 
In addition, thanks to advances in sequencing techniques, the study of the composition 
of the bacterial community and metabolic prediction from the same DNA sample are possible. 
In this regard, changes in the intestinal environment favoured the growth of certain bacteria 
such as Pseudomonas, which increased in abundance. These bacteria are highly ubiquitous and 
are powerful colonisers, capable of forming biofilms. They took advantage of the resources of 
the ecosystem, consuming them, expanding and also limiting the growth of other bacteria-
secreting compounds such as siderophores. Thus, other bacteria were affected in terms of a 
reduction in their abundance. In addition, the metabolic activity of the microbiota of the 
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samples fed with the HFD was also related to processes previously observed in relation to 
obesity and diabetes294.  
The effect of fish oil rich in DHA on the lipid profile and intestinal microbiota of adults 
was also studied. PUFA-rich diets exert a beneficial effect on host health, playing an important 
role in modulating inflammation and intestinal microbial composition250. In this study it was 
noted that the supplementation of the HFD with this oil helped improve the changes in both the 
lipid profile and the microbial community, reversing to a certain extent the variations exerted 
by the HFD. These results are of importance not only for humans, but also for aquaculture 
species. The dietary composition alters the gut microbiota and consequently other aspects of 
fish health. Non-beneficial microbial changes may favour the growth of pathogens in 
aquaculture facilities, which could affect the fish and contribute to economic losses. In addition, 
understanding how dietary nutrients affect fish health and body composition is of importance 
as humans are ultimately the consumers of aquaculture fish. 
Summarizing, the current study demonstrated the usefulness of the zebrafish animal 
model for host-microbiome studies. Dietary modulation of intestinal microbial community, 
inflammation and lipid accumulation is comparable to that in humans, despite the community 
composition differs in terms of phylotypes. Additionally, to study the effect of a particular 
molecules on specific strains of human microbiota, zebrafish represents a suitable model, as 
this study reveals several species of the human flora that colonise and compete inside the 
zebrafish digestive tract.
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1. Obligate anaerobes, which are the most representative microbes of the human flora, 
are able to colonise and compete inside the intestine of axenic zebrafish larvae in 
monoassociation and in consortia. The consortium created from collection strains is 
the first effective SIHUMI described in zebrafish. 
 
2. Several species of the human flora colonise and compete inside the zebrafish digestive 
tract. Among them, highly important members from human flora related to eubiotic 
and dysbiotic state, such as A. muciniphila, F. prausnitzii or Bifidobacterium spp, have 
been identified for the first time as active colonisers of zebrafish model following the 
protocol proposed. 
 
3. Humanised zebrafish has demonstrated to be a powerful model at least during the first 
48 hours of colonisation. Thus, it represents a rapid and cost-effective system for the 
preliminary screening of rapid-action molecules in an alternative vertebrate model. 
 
4. A 10% fat enrichment in the diet induces changes in zebrafish larvae gut microbiota, 
increasing Bacteroidetes and Proteobacteria, which damage the intestinal barrier, 
provoking the activation of immune inflammatory pathways via NF-κB and the 
secretion of protective molecules by the host. 
 
5. In adult zebrafish, the consumption of a diet enriched in fat by 20% led to dysbiosis in 
intestinal microbial composition and metabolism and lipid profile changes correlated 
with the fat accumulation. In addition, predictive inferred metabolism suggests that the 
HFD consumption may induce obesity, diabetes and gut–brain axis effects in zebrafish 
adults, as occurs in humans. 
 
6. HFD supplementation with fish oil rich in DHA exerts a beneficial effect on microbial 
dysbiosis, microbial metabolism and fish lipid profiles in zebrafish adults. 
 
7. Zebrafish at both larvae and adult states, is a suitable model to study host-microbiome 
interactions. The larvae model, is appropriate for the study of microbiota-immune 
system interactions, whereas the adult model is useful to study the relationship 
between the microbiome and the dietary nutrients metabolization.  
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Chapter 2 
Zebrafish axenic Larvae Colonisation with Human Intestinal Microbiota 
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Supplementary Figure 1. Relative abundance of Verrucomicrobia, Actinobacteria and 
Proteobacteria at family level in human and HCONV samples represented in stacked bar chart. 
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Chapter 3 
High-fat diet consumption induces microbiota dysbiosis and intestinal inflammation in 
Zebrafish 
 
Supplementary table 1. List of ingredients of ZF biolabs diet. 
Ingredients ZF biolabs (%) 
Lipids 8 
Proteins 56 
Ash 13 
Water 8 
Fiber 1.4 
Calcium 2 
Sodium 2.5 
Phosphorus 1.5 
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Chapter 4 
Host-microbiota interactions in response to a high-fat diet and fish oil supplementation 
in zebrafish adults 
 
Supplementary table 2. Experimental dietary fatty acid composition: Control, HFD, 
Sendabio DHA, HFO and HFO diet after one week of storage at 4◦C (*). 
 
Fatty acids Control HFD Sendabio DHA HFO HFO* 
Butiric C4:0 0.00 0.00 0 0.00 0.00 
Caproic C6:0 0.00 0.00 0 0.00 0.00 
Caprilic C8:0 0.00 0.00 0 0.03 0.05 
Capric C10:0 0.00 0.00 0 0.02 0.04 
Lauric C12:0 0.00 0.00 0 0.02 0.00 
Miristic C14:0 2.37 0.72 0 0.80 0.40 
Miristoleic C14:1 0.00 0.00 0 0.00 0.00 
Palmitic C16:0 13.65 22.83 0,06 21.17 20.42 
Palmitoleic C16:1 2.75 0.85 0,05 0.89 0.55 
Margaric C17:0 1.14 0.26 0 0.25 0.23 
Estearic C18:0 4.01 26.21 0,22 22.10 27.08 
Oleic C18:1 16.50 28.27 0,04 24.30 27.59 
Linoleic C18:2 14.56 9.70 0,03 10.93 4.03 
Linolenic C18:3n6 0.00 0.05 0 0.05 0.00 
Linolenic C18:3n3 0.00 0.05 0 0.05 0.00 
Estearidonic C18:4 1.31 0.21 0,05 0.12 0.28 
Arachidic C20:0 0.33 0.88 0,00 0.77 0.87 
Eicosenoic C20:1 4.62 1.06 0,00 1.11 0.70 
Arachidonic C20:4n6 1.09 0.25 0,45 0.28 0.22 
Eicosatetraenoic C20:4n3 0.37 0.11 0,21 0.10 0.07 
EPA C20:5 7.44 1.71 2,29 1.86 1.35 
Behenic C22:0 0.22 0.24 0 0.25 0.18 
Erucic C22:1 6.54 1.16 0 1.20 1.00 
Clupanodonic C22:5 1.26 0.26 2,08 0.64 0.47 
Lignoceric C24:0 0.00 0.13 0,35 0.14 0.12 
DHA C22:6 19.91 4.12 83,30 11.87 13.96 
% SFA 21.72 51.26 - 45.55 49.38 
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% MUFA 30.42 31.33 - 27.51 29.85 
% PUFA 47.87 17.41 - 26.94 20.77 
 
 
Supplementary table 3. Gene expression primer list. 
Gene Short Forward primer Reverse primer Ref 
Insuline growth 
factor 1 
IGF1 GCATTGGTGTGATGTCTTTAAGTGTA GTTTGCTGAAATAAAAGCCCCT 295 
Insuline growth 
factor 2 
IGF2 GAAACACGAACAACGATGCG AGTACTTCACATTTATGGTGTCCTTG 295 
fatty acid 
synthase 
FASN CGCTTGTCCTACTTCTTTGATTTCA TTCCAGTGCCAGCAGACTAGAG 296 
peroxisome 
proliferator 
activated 
receptor 
PPARg GGCATGTCACACAACGCG CCTTCTCAGCCTGCGGC 258 
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Supplementary table 4. Median of the total content of whole zebrafish and liver fatty acids. The 
results are expressed as a median. MAD*2 is the median absolute deviation. Differences were considered 
statistically significant at p < 0.05 (*) and p < 0.01 (**). 
Zebrafish  
Fatty Acids % 
Control MAD*2 HFD MAD*2 HFO MAD*2 
p 
C-HFD 
p 
HFD-HFO 
C10:0 0.0000 0 0.0000 0 0.0159 ±0.003  ** 
C12:0 0.0571 ±0.002 0.0339 ±0.002 0.0372 ±0.006 ** 
 
C14:0 1.9536 ±0.041 1.0349 ±0.052 0.9667 ±0.048 ** 
 
C14:1 0.0532 ±0.017 0.0349 ±0.009 0.0323 ±0.005 ** 
 
C16:0 19.6873 ±0.134 20.7509 ±0.503 17.8604 ±0.932 * ** 
C16:1 2.6552 ±0.174 1.7294 ±0.041 1.5238 ±0.096 ** * 
C17:0 0.4427 ±0.027 0.3152 ±0.073 0.2901 ±0.04 ** 
 
C18:0 3.9202 ±0.590 10.3515 ±0.245 10.1854 ±0.397 ** 
 
C18:1 17.8948 ±0.223 32.2668 ±2.5 27.9423 ±1.924 ** ** 
C18:2 26.3517 ±1.311 16.7897 ±1.845 15.6457 ±1.813 ** 
 
C18:3 3.0229 ±0.197 1.7803 ±0.043 1.7730 ±0.209 ** 
 
C18:4 0.3104 ±0.045 0.2967 ±0.071 0.2426 ±0.126  * 
C20:0 0.1144 ±0.012 0.1499 ±0.021 0.1703 ±0.004 ** * 
C20:1 2.0123 ±0.104 1.1773 ±0.045 1.2418 ±0.045 ** 
 
C20:4n6 0.8666 ±0.157 0.6380 ±0.125 0.6400 ±0.155 ** 
 
C20:4n3 0.6148 ±0.026 0.3395 ±0.008 0.3677 ±0.037 ** 
 
C20:5 3.8185 ±0.197 2.3197 ±0.091 3.1472 ±0.364 ** ** 
C22:0 0.0833 ±0.007 0.0690 ±0.005 0.0785 ±0.005 ** 
 
C22:1 1.1157 ±0.222 0.7712 ±0.082 0.7721 ±0.023 ** 
 
C22:5 1.0692 ±0.08 0.6400 ±0.044 0.8469 ±0.131 ** ** 
C24:0 0.0000 0 0.0000 ±0 0.0279 ±0.001  
 
C22:6 11.7808 ±2.139 8.1919 ±0.927 15.3734 ±0.735 ** ** 
Omega 6 (total) 27.2688 ±1.255 17.4582 ±2.040 16.2082 ±1.658 ** 
 
Omega 3 (total) 20.6307 ±2.015 13.1289 ±1.235 21.0938 ±1.821 ** ** 
Omega 6/Omega3 1.3218 ±0.181 1.2684 ±0.145 0.7688 ±0.079  ** 
% SFA 26.6115 ±1.308 32.5039 ±0.996 29.6622 ±0.867 ** ** 
% MUFA 23.8402 ±0.358 36.0264 ±2.025 31.3864 ±1.769 ** ** 
% PUFA 48.2329 ±0.528 30.4813 ±1.633 36.9647 ±0.779 ** ** 
EPA + DHA 15.7276 ±2.427 10.3427 ±1.264 18.1833 ±1.790 ** ** 
 
  
Supplementary material 
 
149 
Liver  
Fatty Acids % Control MAD*2 HFD MAD*2 HFO MAD*2 
p 
C-HFD 
P 
HFD-
HFO 
C10:0 0.028 0.031 0.013 0.027 0 0   
C12:0 0.017 0.035 0.018 0.009 0 0   
C14:0 0.048 0.070 0 0 0 0   
C14:1 0.553 0.306 0.515 0.096 0.224 0.1146   
C16:0 12.258 8.905 14.664 1.689 8.155 4.10  * 
C16:1 0.787 0.751 0.733 0.354 0.304 0.176   
C17:0 0.323 0.192 0.180 0.04 0.151 0.036   
C18:0 4.504 1.662 9.142 3.159 6.370 2.985 * * 
C18:1 7.94 1.732 17.089 2.76 8.173 5.224 * * 
C18:2 8.953 7.204 7.486 4.2874 3.757 2.626   
C18:3 0.925 0.407 0.734 0.399 0.465 0.083   
C18:4 24.572 20.216 19.658 9.203 27.054 7.224   
C20:0 0.095 0.097 0.092 0.005 0.088 0.042   
C20:1 1.353 0.937 0.892 0.068 1.018 0.160   
C20:4n6 0.961 0.174 1.100 0.275 1.000 0.376   
C20:4n3 0.599 0.087 0.420 0.060 0.544 0.074 *  
C20:5 1.967 1.457 1.760 0.375 2.081 0.6722   
C22:0 0 0 0.031 0.063 0 0   
C22:1 0.294 0.519 0.312 0.125 0.129 0.14   
C22:5 0.9347 0.446 0.833 0.156 1.552 0.9972  * 
C24:0 8.94 4.069 9.157 3.275 10.798 5.5554   
C22:6 10.931 8.01 8.974 5.522 5.223 2.7582   
Omega 6 (total) 14.288 1.989 13.700 3.830 15.978 8.5396   
Omega 3 (total) 0.732 0.157 0.7569 0.389 0.326 0.060   
Omega 
6/Omega3 
2.009 0.709 1.742 0.091 1.282 0.285 
  
% SFA 18.141 9.78 24.189 5.865 16.459 4.399  * 
% MUFA 9.931 2.18 19.102 3.316 9.798 5.75   
% PUFA 51.290 3.09 40.741 1.527 51.607 2.606 ** ** 
EPA + DHA 10.951 3.99 11.616 3.694 13.378 4.662   
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Supplementary Figure 2. Experimental diets design schema. 
 
 
 
Supplementary Figure 3. Correlation plot showing Pearson correlations between fatty 
acid lipid profile and gene expression in the intestine and liver. Blue dots are positive 
correlations, whereas red dots are negative correlations. Only significant correlations are 
represented (p < 0.05). 
  
  
 
